

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>New perspectives on the regulation of type II... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1014/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1014" />
    
            <meta name="description" content="Read the original article in full on F1000Research: New perspectives on the regulation of type II inflammation in asthma" />
    
            <meta name="og:title" content="F1000Research Article: New perspectives on the regulation of type II inflammation in asthma.">
            <meta name="og:description" content="Read the latest article version by Mireya Becerra-D&iacute;az, Marsha Wills-Karp, Nicola M. Heller, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12082">
            <meta name="article-id" content="11198">
            <meta name="dc.title" content="New perspectives on the regulation of type II inflammation in asthma">
            <meta name="dc.description" content="Asthma is a chronic inflammatory disease of the lungs which has been thought to arise as a result of inappropriately directed T helper type-2 (Th2) immune responses of the lungs to otherwise innocuous inhaled antigens. Current asthma therapeutics are directed towards the amelioration of downstream consequences of type-2 immune responses (i.e. &beta;-agonists) or broad-spectrum immunosuppression (i.e. corticosteroids). However, few approaches to date have been focused on the primary prevention of immune deviation. Advances in molecular phenotyping reveal heterogeneity within the asthmatic population with multiple endotypes whose varying expression depends on the interplay between numerous environmental factors and the inheritance of a broad range of susceptibility genes. The most common endotype is one described as &ldquo;type-2-high&rdquo; (i.e. high levels of interleukin [IL]-13, eosinophilia, and periostin). The identification of multiple endotypes has provided a potential explanation for the observations that therapies directed at typical Th2 cytokines (IL-4, IL-5, and IL-13) and their receptors have often fallen short when they were tested in a diverse group of asthmatic patients without first stratifying based on disease endotype or severity. However, despite the incorporation of endotype-dependent stratification schemes into clinical trial designs, variation in drug responses are still apparent, suggesting that additional genetic/environmental factors may be contributing to the diversity in drug efficacy. Herein, we will review recent advances in our understanding of the complex pathways involved in the initiation and regulation of type-2-mediated immune responses and their modulation by host factors (genetics, metabolic status, and the microbiome). Particular consideration will be given to how this knowledge could pave the way for further refinement of disease endotypes and/or the development of novel therapeutic strategies for the treatment of asthma . ">
            <meta name="dc.subject" content="asthma, Th2 inflammation, cytokines, alarmins, cellular metabolism, signalling, allergic inflammation">
            <meta name="dc.creator" content="Becerra-D&iacute;az, Mireya">
            <meta name="dc.creator" content="Wills-Karp, Marsha">
            <meta name="dc.creator" content="Heller, Nicola M.">
            <meta name="dc.date" content="2017/06/28">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11198.1">
            <meta name="dc.source" content="F1000Research 2017 6:1014">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="asthma">
            <meta name="prism.keyword" content="Th2 inflammation">
            <meta name="prism.keyword" content="cytokines">
            <meta name="prism.keyword" content="alarmins">
            <meta name="prism.keyword" content="cellular metabolism">
            <meta name="prism.keyword" content="signalling">
            <meta name="prism.keyword" content="allergic inflammation">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/06/28">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1014">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11198.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1014">
            <meta name="citation_title" content="New perspectives on the regulation of type II inflammation in asthma">
            <meta name="citation_abstract" content="Asthma is a chronic inflammatory disease of the lungs which has been thought to arise as a result of inappropriately directed T helper type-2 (Th2) immune responses of the lungs to otherwise innocuous inhaled antigens. Current asthma therapeutics are directed towards the amelioration of downstream consequences of type-2 immune responses (i.e. &beta;-agonists) or broad-spectrum immunosuppression (i.e. corticosteroids). However, few approaches to date have been focused on the primary prevention of immune deviation. Advances in molecular phenotyping reveal heterogeneity within the asthmatic population with multiple endotypes whose varying expression depends on the interplay between numerous environmental factors and the inheritance of a broad range of susceptibility genes. The most common endotype is one described as &ldquo;type-2-high&rdquo; (i.e. high levels of interleukin [IL]-13, eosinophilia, and periostin). The identification of multiple endotypes has provided a potential explanation for the observations that therapies directed at typical Th2 cytokines (IL-4, IL-5, and IL-13) and their receptors have often fallen short when they were tested in a diverse group of asthmatic patients without first stratifying based on disease endotype or severity. However, despite the incorporation of endotype-dependent stratification schemes into clinical trial designs, variation in drug responses are still apparent, suggesting that additional genetic/environmental factors may be contributing to the diversity in drug efficacy. Herein, we will review recent advances in our understanding of the complex pathways involved in the initiation and regulation of type-2-mediated immune responses and their modulation by host factors (genetics, metabolic status, and the microbiome). Particular consideration will be given to how this knowledge could pave the way for further refinement of disease endotypes and/or the development of novel therapeutic strategies for the treatment of asthma . ">
            <meta name="citation_description" content="Asthma is a chronic inflammatory disease of the lungs which has been thought to arise as a result of inappropriately directed T helper type-2 (Th2) immune responses of the lungs to otherwise innocuous inhaled antigens. Current asthma therapeutics are directed towards the amelioration of downstream consequences of type-2 immune responses (i.e. &beta;-agonists) or broad-spectrum immunosuppression (i.e. corticosteroids). However, few approaches to date have been focused on the primary prevention of immune deviation. Advances in molecular phenotyping reveal heterogeneity within the asthmatic population with multiple endotypes whose varying expression depends on the interplay between numerous environmental factors and the inheritance of a broad range of susceptibility genes. The most common endotype is one described as &ldquo;type-2-high&rdquo; (i.e. high levels of interleukin [IL]-13, eosinophilia, and periostin). The identification of multiple endotypes has provided a potential explanation for the observations that therapies directed at typical Th2 cytokines (IL-4, IL-5, and IL-13) and their receptors have often fallen short when they were tested in a diverse group of asthmatic patients without first stratifying based on disease endotype or severity. However, despite the incorporation of endotype-dependent stratification schemes into clinical trial designs, variation in drug responses are still apparent, suggesting that additional genetic/environmental factors may be contributing to the diversity in drug efficacy. Herein, we will review recent advances in our understanding of the complex pathways involved in the initiation and regulation of type-2-mediated immune responses and their modulation by host factors (genetics, metabolic status, and the microbiome). Particular consideration will be given to how this knowledge could pave the way for further refinement of disease endotypes and/or the development of novel therapeutic strategies for the treatment of asthma . ">
            <meta name="citation_keywords" content="asthma, Th2 inflammation, cytokines, alarmins, cellular metabolism, signalling, allergic inflammation">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Mireya Becerra-D&iacute;az">
            <meta name="citation_author_institution" content="Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA">
            <meta name="citation_author" content="Marsha Wills-Karp">
            <meta name="citation_author_institution" content="Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA">
            <meta name="citation_author" content="Nicola M. Heller">
            <meta name="citation_author_institution" content="Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA">
            <meta name="citation_publication_date" content="2017/06/28">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1014">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11198.1">
            <meta name="citation_firstpage" content="1014">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1014/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1014.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12082 /> <input type=hidden id=articleId name=articleId value=11198 /> <input type=hidden id=xmlUrl value="/articles/6-1014/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1014-v1.xml"> <input type=hidden id=article_uuid value=eacdf954-427a-4c4a-adc2-6818e2c5df34 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="New perspectives on the regulation of type II inflammation in asthma"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11198.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11198.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1014"
  },
  "headline": "New perspectives on the regulation of type II inflammation in asthma",
  "datePublished": "2017-06-28T10:34:35",
  "dateModified": "2017-06-28T10:34:35",
  "author": [
    {
      "@type": "Person",
      "name": "Mireya Becerra-D&iacute;az"
    },    {
      "@type": "Person",
      "name": "Marsha Wills-Karp"
    },    {
      "@type": "Person",
      "name": "Nicola M. Heller"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Asthma is a chronic inflammatory disease of the lungs which has been thought to arise as a result of inappropriately directed T helper type-2 (Th2) immune responses of the lungs to otherwise innocuous inhaled antigens. Current asthma therapeutics are directed towards the amelioration of downstream consequences of type-2 immune responses (i.e. &beta;-agonists) or broad-spectrum immunosuppression (i.e. corticosteroids). However, few approaches to date have been focused on the primary prevention of immune deviation. Advances in molecular phenotyping reveal heterogeneity within the asthmatic population with multiple endotypes whose varying expression depends on the interplay between numerous environmental factors and the inheritance of a broad range of susceptibility genes. The most common endotype is one described as &ldquo;type-2-high&rdquo; (i.e. high levels of interleukin [IL]-13, eosinophilia, and periostin). The identification of multiple endotypes has provided a potential explanation for the observations that therapies directed at typical Th2 cytokines (IL-4, IL-5, and IL-13) and their receptors have often fallen short when they were tested in a diverse group of asthmatic patients without first stratifying based on disease endotype or severity. However, despite the incorporation of endotype-dependent stratification schemes into clinical trial designs, variation in drug responses are still apparent, suggesting that additional genetic/environmental factors may be contributing to the diversity in drug efficacy. Herein, we will review recent advances in our understanding of the complex pathways involved in the initiation and regulation of type-2-mediated immune responses and their modulation by host factors (genetics, metabolic status, and the microbiome). Particular consideration will be given to how this knowledge could pave the way for further refinement of disease endotypes and/or the development of novel therapeutic strategies for the treatment of asthma."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1014",
            "name": "New perspectives on the regulation of type II inflammation in asthma"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> New perspectives on the regulation of type II inflammation in asthma </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12082 data-id=11198 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11198.1" data-recommended="" data-doi="10.12688/f1000research.11198.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1014/v1/pdf?article_uuid=eacdf954-427a-4c4a-adc2-6818e2c5df34" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11198-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11198-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11198-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Becerra-Díaz M, Wills-Karp M and Heller NM. New perspectives on the regulation of type II inflammation in asthma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1014 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11198.1" target=_blank>https://doi.org/10.12688/f1000research.11198.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11198-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11198 id=track-article-signin-11198 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11198?target=/articles/6-1014">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12082 /> <input name=articleId type=hidden value=11198 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>New perspectives on the regulation of type II inflammation in asthma</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:mbecerr1@jhmi.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mireya Becerra-D&iacute;az</span></a><sup>1</sup>,&nbsp;</span><span class="">Marsha Wills-Karp<a href="https://orcid.org/0000-0001-7247-2021" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7247-2021</div><sup>2</sup>,&nbsp;</span><span class="">Nicola M. Heller<a href="https://orcid.org/0000-0001-7247-2021" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7247-2021</div><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:mbecerr1@jhmi.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mireya Becerra-D&iacute;az</span></a><sup>1</sup>,&nbsp;</span><span class="">Marsha Wills-Karp<a href="http://orcid.org/0000-0001-7247-2021" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7247-2021</div><sup>2</sup>,&nbsp;</span><span class="">Nicola M. Heller<a href="http://orcid.org/0000-0001-7247-2021" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7247-2021</div><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 28 Jun 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11198.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA<br/> <sup>2</sup> Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23591-23856></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23592-23857></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Asthma is a chronic inflammatory disease of the lungs which has been thought to arise as a result of inappropriately directed T helper type-2 (Th2) immune responses of the lungs to otherwise innocuous inhaled antigens. Current asthma therapeutics are directed towards the amelioration of downstream consequences of type-2 immune responses (i.e. β-agonists) or broad-spectrum immunosuppression (i.e. corticosteroids). However, few approaches to date have been focused on the primary prevention of immune deviation. Advances in molecular phenotyping reveal heterogeneity within the asthmatic population with multiple endotypes whose varying expression depends on the interplay between numerous environmental factors and the inheritance of a broad range of susceptibility genes. The most common endotype is one described as “type-2-high” (i.e. high levels of interleukin [IL]-13, eosinophilia, and periostin). The identification of multiple endotypes has provided a potential explanation for the observations that therapies directed at typical Th2 cytokines (IL-4, IL-5, and IL-13) and their receptors have often fallen short when they were tested in a diverse group of asthmatic patients without first stratifying based on disease endotype or severity. However, despite the incorporation of endotype-dependent stratification schemes into clinical trial designs, variation in drug responses are still apparent, suggesting that additional genetic/environmental factors may be contributing to the diversity in drug efficacy. Herein, we will review recent advances in our understanding of the complex pathways involved in the initiation and regulation of type-2-mediated immune responses and their modulation by host factors (genetics, metabolic status, and the microbiome). Particular consideration will be given to how this knowledge could pave the way for further refinement of disease endotypes and/or the development of novel therapeutic strategies for the treatment of asthma<b>.</b> </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> asthma, Th2 inflammation, cytokines, alarmins, cellular metabolism, signalling, allergic inflammation </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Mireya Becerra-D&iacute;az (<a href="mailto:mbecerr1@jhmi.edu">mbecerr1@jhmi.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Mireya Becerra-Díaz </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was funded by NIH R01HL124477 to Nicola M. Heller for Mireya Becerra-Díaz and Nicola M. Heller and NIH RO1AI083315 and NIH U19AI070235 to Marsha Wills-Karp. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Becerra-Díaz M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Becerra-Díaz M, Wills-Karp M and Heller NM. New perspectives on the regulation of type II inflammation in asthma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1014 (<a href="https://doi.org/10.12688/f1000research.11198.1" target=_blank>https://doi.org/10.12688/f1000research.11198.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 28 Jun 2017, <b>6</b>(F1000 Faculty Rev):1014 (<a href="https://doi.org/10.12688/f1000research.11198.1" target=_blank>https://doi.org/10.12688/f1000research.11198.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 28 Jun 2017, <b>6</b>(F1000 Faculty Rev):1014 (<a href="https://doi.org/10.12688/f1000research.11198.1" target=_blank>https://doi.org/10.12688/f1000research.11198.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e209>Introduction</h2><p class="" id=d7202e212>Asthma is a phenotypically heterogeneous inflammatory disease of the lungs generally characterized by airflow obstruction and airway inflammation. Advances in molecular phenotyping reveal heterogeneity within the asthmatic population with multiple endotypes<sup><a href="#ref-1">1</a>–<a href="#ref-3">3</a></sup> whose varying expression depends on the interplay between numerous environmental factors and the inheritance of a broad range of susceptibility genes. Patients with a type-2-high profile are found in half of the mild asthmatic patients and are reported to be responsive to steroids<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. The type-2-high asthma endotype is one of the most consistent endotypes to emerge<sup><a href="#ref-3">3</a>–<a href="#ref-9">9</a></sup>. This common subtype of asthma is characterized by the release of signature cytokines interleukin (IL)-4, IL-5, and IL-13 from cells of both the innate and the adaptive immune systems. These type-2 cytokines are targets for pharmaceutical intervention, and a number of therapeutic options are under clinical investigation for asthma. These will be discussed in detail below. The identification of multiple endotypes has provided an explanation for the observations that therapies directed at these typical T helper type-2 (Th2) cytokines and their receptors have often fallen short when they were tested in a diverse group of asthmatic patients without first stratifying based on disease endotype or severity. The stratification of patients in clinical trials based on specific endotypes has lent support for continued efforts to modify IL-4 and IL-13 pathways in type-2-high asthma, yet additional variation in treatment response is still apparent. These results suggest that regulation of type-2 cytokine production and responsiveness is more complex than was previously appreciated and that other genetic/environmental factors may be contributing to the diversity in drug response. As many ongoing efforts are designed to target the type-2 immune response, it is critical to fully understand the intricacies of regulation of this arm of the immune response. In this review, we will discuss new insights into the mechanisms by which IL-4- and IL-13-mediated inflammation is initiated, enhanced, perpetuated, or inhibited, with a focus on new players that modulate IL-4 and IL-13 responses. Although we will touch briefly on IL-5 as an additional important Th2 cytokine in promoting the allergic inflammatory response, we will focus our comments here on IL-4 and IL-13. We will highlight how some of the new pathways that influence IL-4 and IL-13 responses might potentially be harnessed for therapeutic benefit to downregulate type-2 immune responses in type-2-high asthmatics.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e239>Role of canonical Th2 pathways in allergic inflammation</h2><p class="" id=d7202e242>The Th2 immune response is characterized by the expansion of CD4<sup>+</sup> T cells producing the prototypical Th2 cytokines IL-4, IL-13, and IL-5. Although IL-9 was originally thought to be produced by Th2 cells, more recent studies suggest that it is primarily produced by a unique CD4<sup>+</sup> T cell subset referred to as Th9<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>. More recent studies show that other cell types such as type-2 innate lymphoid cells (ILC2s), mast cells, and eosinophils also produce these type-2-associated cytokines. These cytokines act on multiple cell types and trigger the hallmark features of a type-2 immune response, including the synthesis of immunoglobulin (Ig)E, eosinophilia, mast cell activation, mucus cell hyperplasia, and macrophage polarization. Although a type-2 immune response is critical in host defense against helminth infections, inappropriate activation of type-2 responses against otherwise innocuous antigens leads to allergic responses in different barrier organs, such as the skin, gut, and lungs.</p><p class="" id=d7202e258>Aberrant production of the prototypical type-2 cytokines IL-4 and IL-13 has long been associated with the pathogenesis of allergic disorders<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. The overproduction of mucus resulting in airway obstruction in asthma is an effect of IL-4/IL-13 action on goblet cells, inducing mucin gene expression, hyperplasia, and hypertrophy<sup><a href="#ref-14">14</a></sup>. IL-4 and IL-13 also have direct effects on airway smooth muscle cells that may explain the hypercontractility of these cells in the airways of asthmatics<sup><a href="#ref-15">15</a></sup>. IL-4 and IL-13 also induce chemokine release from airway smooth muscle cells<sup><a href="#ref-16">16</a></sup>. The activity of IL-4 and IL-13 on the structural cells of the lung such as vascular endothelial cells and airway epithelial cells elicits the expression of adhesion molecules, chemokines, and transforming growth factor (TGF)-β production. These molecules direct the influx of circulating inflammatory cells, such as eosinophils, basophils, and others, to the lung tissue and airway lumen and induce lung tissue remodeling. Neutrophils also migrate into the lungs during allergic inflammation, but they are particularly elevated in patients with severe asthma. These patients are different from the type-2-high endotype and their disease is believed to be driven by Th17-mediated inflammation. As such, they are also typically unresponsive to the IL-4-/IL-13-directed therapies discussed in the previous section and to treatment with corticosteroids. IL-4 enhances the capacity of dendritic cells (DCs) to stimulate T cell secretion of Th2 cytokines, whereas IL-13 enhances the capacity of DCs to suppress T cell secretion of interferon (IFN)-γ in mice<sup><a href="#ref-17">17</a></sup>. Both IL-4 and IL-13 increase DC antigen uptake<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup> and cell migration into the lymph nodes where they prime naive T cells to differentiate into Th2 cells<sup><a href="#ref-20">20</a></sup>. B cell class switching to production of IgE is driven by IL-4<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup> and by IL-13 in human but not in mouse B cells, which lack IL-13 receptor α1 (IL-13Rα1)<sup><a href="#ref-23">23</a></sup>. Fibroblast responses to IL-4 and IL-13 contribute indirectly to the lung remodeling that occurs in chronic asthma by eliciting the production of adhesion molecules and chemokines as well as cytokines that then stimulate epithelial cells to secrete TGF-β1<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d7202e311>The eosinophilia observed in asthma and allergic diseases is partially controlled by the Th2 cytokine IL-5. IL-5 is critical for the genesis (in the bone marrow)<sup><a href="#ref-23">23</a></sup>, growth<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>, and survival of eosinophils. Eosinophils are a key target of therapeutic strategies in the treatment of allergic disease because of their ability to cause tissue damage and inflammation following the activation and release of a toxic mixture of their different granule proteins in inflamed tissue. IL-5 acts on eosinophils by binding to its receptor (IL-5R), which is a heterodimer composed of two chains: one α subunit (which binds IL-5) and one β subunit (which is implicated in signal transduction)<sup><a href="#ref-25">25</a></sup>. Accordingly, blocking IL-5 with antibodies has been useful at lowering peripheral and sputum eosinophil counts in asthmatics. While several studies indicate that anti-IL-5 treatment had no effect on improvement in quality of life measures in asthmatics compared to placebo controls<sup><a href="#ref-26">26</a></sup>, others have demonstrated that patients have fewer exacerbations concomitant with reduction in blood eosinophil counts<sup><a href="#ref-27">27</a></sup>. Beyond blocking IL-5, blocking the IL-5 receptor has also been an important therapeutic target against asthma. Currently, two anti-IL-5 antibodies are FDA approved for use in asthmatics older than 12 years of age<sup><a href="#ref-27">27</a></sup>, and a third antibody, which binds the IL-5Rα, is now in phase III clinical trials<sup><a href="#ref-28">28</a></sup>. However, as mentioned above, blocking IL-5 alone is not sufficient to decrease asthma severity. Future trials combining the blockade of IL-5/IL-5R together with other therapies will provide more robust strategies to improve quality of life in asthmatic patients.</p><p class="" id=d7202e346>Lung macrophages (alveolar and interstitial macrophages) are critical regulators of lung homeostasis and the inflammatory response to inhaled allergens<sup><a href="#ref-29">29</a></sup>. Similar to T cells, lung macrophages that encounter IL-4 and IL-13 polarize into a distinct phenotype, formerly known as “alternatively activated” or M2 macrophages. M2 macrophages express arginase I (ARG1) and other hallmark M2 gene products, such as YM1 and Found in Inflammatory Zone (FIZZ)1 in mice<sup><a href="#ref-30">30</a></sup>. This is in contrast to Th1 cytokines, viruses, and microbes that induce skewing to M1 macrophages and that express inducible nitric oxide synthase (iNOS), IL-1β, tumor necrosis factor (TNF)-α, and other pro-inflammatory mediators<sup><a href="#ref-31">31</a></sup>. Although both M1 and M2 macrophages are found in the lung during the course of allergic inflammation, M2 macrophages are increased in the lungs of asthmatics compared to healthy controls, and their abundance correlates with declines in lung function<sup><a href="#ref-32">32</a>–<a href="#ref-38">38</a></sup>. Mouse models of allergic inflammation recapitulate the observations in humans<sup><a href="#ref-39">39</a>–<a href="#ref-42">42</a></sup>. Adoptive transfer experiments revealed that the transfer of IL-4Rα-sufficient macrophages, but not IL-4Rα-deficient macrophages, into RAG2<sup>–/–</sup> mice was sufficient for the development of allergen-driven lung eosinophilia<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d7202e384>M2 macrophages are thought to promote allergic lung inflammation through the secretion of angiogenic and pro-fibrotic factors, including vascular endothelial growth factor, insulin-like growth factor (IGF)-I, TGF-β1, matrix metalloproteinases (MMPs), acidic mammalian chitinase (AMCase), BRP-39/YKL-40<sup><a href="#ref-43">43</a></sup>, and FIZZ1<sup><a href="#ref-44">44</a>–<a href="#ref-46">46</a></sup>, that have the potential to promote lung remodeling. M2 macrophages also produce many inflammatory cell-recruiting chemokines (CCL11, 24, and 26, YM1, and others) that recruit eosinophils, basophils, T cells, and other immune cell types to the inflamed lung. Lastly, M2 macrophages have immunomodulatory properties also through direct and indirect effects on T cells, airway epithelium, and DCs<sup><a href="#ref-47">47</a>–<a href="#ref-49">49</a></sup>. Since alveolar macrophages are one of the “first responders” to inhaled allergens and owing to their key role in immunomodulation and maintaining homeostasis, modifying their phenotype and function is an attractive concept for intervention.</p><p class="" id=d7202e405>In the section below, we will describe how IL-4 and IL-13 regulate most of the features of allergic inflammation through their interaction with the IL-4/IL-13 receptor complexes and downstream signaling in multiple cell types. We will also highlight how new insights into these processes could provide opportunities for the development of therapeutic intervention in asthmatics.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e411>IL-4 and IL-13 cytokine receptor regulation</h2><p class="" id=d7202e414>IL-4 and IL-13 are functionally and structurally related cytokines that have both overlapping and unique biological responses owing, in part, to the utilization of a combination of shared and unique receptors<sup><a href="#ref-12">12</a>,<a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup>. IL-4 is recognized by two types of membrane receptors, type I (IL-4Rα and the common gamma-chain [γc]) and type II (IL-4Rα and IL-13Rα1), while IL-13 is recognized only by the type II IL-4 receptor. IL-13 is also bound with incredibly high affinity by IL-13Rα2, which exists in membrane-bound and soluble forms. IL-4 promotes and maintains the polarization of Th2 cells through ligating the type I IL-4R<sup><a href="#ref-52">52</a></sup>, whereas IL-13 has no effect on T cells because of their lack of IL-13Rα1 expression. On the other hand, IL-13 is thought to be more important in the induction of the physiological aspects of allergic asthma, including airway hyper-responsiveness (AHR), mucus hypersecretion, airway smooth muscle alterations, and subepithelial fibrosis, than IL-4<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. The exact molecular mechanism(s) by which these two cytokines regulate distinct features of the allergic response and how their contributions, either individually or in concert, induce the pathophysiological manifestations of disease remain to be fully uncovered. Recent discoveries of differences in utilization/assembly and affinity of IL-4 and IL-13 for the type-2 receptor and the regulation of the receptors along with the discovery of unique ILC2s which preferentially produce IL-13, and not IL-4, are beginning to shed light on these mysteries<sup><a href="#ref-12">12</a></sup>. Moreover, the identification of new cellular and molecular pathways affecting the regulation of IL-4/IL-13 receptor chains is painting a very complex picture in which a series of intricate feedback loops serve to keep the expression of type-2 inflammation in check. Understanding this delicate balance and how it is disturbed in asthma may inform the development of novel therapeutic approaches for the treatment of asthma.</p><div class=section><a name=d7202e442 class=n-a></a><h3 class=section-title>IL-4Rα</h3><p class="" id=d7202e447>Given the importance of IL-4Rα in triggering Th2 inflammation<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup> and the strong association between polymorphisms in this gene and asthma risk<sup><a href="#ref-56">56</a>–<a href="#ref-58">58</a></sup>, understanding the mechanisms by which IL-4Rα expression is controlled is critical. In this regard, recent studies suggest a role for STUB1 (STIPI homology and U-box-containing protein 1), a chaperone-dependent E3 ubiquitin ligase<sup><a href="#ref-59">59</a></sup> which interacts with IL-4Rα and targets it for proteasomal degradation to regulate signaling. STUB1-deficient mice show spontaneous airway inflammation, alternative M2 activation, and increased serum IgE levels, which was correlated with increased IL-4Rα expression. Interestingly, STUB1 mRNA levels are up-regulated in the airways of subjects with asthmatic and chronic obstructive pulmonary disease (COPD), suggesting that elevation of STUB1 expression may serve as a possible feedback mechanism in an effort to dampen IL-4Rα signaling<sup><a href="#ref-60">60</a></sup>. The development of strategies to modulate STUB1 activity may represent a promising approach for targeting IL-4-/IL-13-dependent allergic inflammation.</p><p class="" id=d7202e472>Several therapeutic strategies aimed at blocking IL-4Rα-initiated signaling have been attempted. These approaches include treatment with a variant IL-4R protein and with several individual monoclonal antibodies directed against IL-4Rα. First, a variant of the IL-4 protein, pitrakinra, that contains two amino acid changes that allow it to bind the IL-4Rα-chain, without allowing it to complex with either the γC or the IL-13Rα1 chains, has shown some promise. In an allergen challenge study, treatment with nebulized pitrakinra resulted in a decrease in the late-phase allergic response measured by FEV1<sup><a href="#ref-61">61</a></sup>. A larger follow-up study of symptomatic moderate-to-severe adult asthmatics using corticosteroids revealed that although there was no therapeutic benefit for the entire population treated with pitrakinra compared to placebo, there was a significant reduction in asthma exacerbations in a pre-specified subset of subjects with high blood eosinophil counts<sup><a href="#ref-62">62</a></sup>. A later study revealed a pharmacologic interaction between therapy and variation (IL4RA Q576R) within the gene encoding the IL-4Rα chain (<i>IL-4RA</i>), identifying an asthma subgroup that was more responsive to pitrakinra<sup><a href="#ref-63">63</a></sup>. Another strategy to block IL-4Rα signaling has been to treat with humanized high-affinity monoclonal antibodies directed against IL-4Rα (AMG-317, dupilumab). A randomized controlled phase IIA trial showed that treatment with dupilumab (SAR231893/REGN668, NCT01312961) prevented asthma exacerbations when long-acting β-agonists and inhaled corticosteroid were withheld in patients with moderate-to-severe asthma as compared to placebo<sup><a href="#ref-5">5</a></sup>. Phase III studies are underway which should provide more definitive information regarding the efficacy of blocking the IL-4Rα in asthma.</p></div><div class=section><a name=d7202e495 class=n-a></a><h3 class=section-title>IL-13Rα1</h3><p class="" id=d7202e500>As discussed above, the role of IL-13Rα1 in mediating Th2 inflammation such as in AHR, mucus production, and fibrosis is well known<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>. IL-13Rα1<sup>–/–</sup> mice did not develop AHR nor mucus production and had decreased IgE titers in a schistosomal egg antigen-induced model of allergic lung inflammation<sup><a href="#ref-66">66</a></sup>. Similarly, challenging the IL-13Rα1<sup>–/–</sup> mice with IL-13, IL-4, or OVA resulted in no mucus production and protection from AHR<sup><a href="#ref-64">64</a></sup>. These studies demonstrate the critical role of IL-13Rα1 in the generation of AHR and mucus production. The development of the fibrotic response is also dependent on IL-13Rα1 in both the schistosomal and the allergic lung inflammation models of Th2 inflammation<sup><a href="#ref-64">64</a>,<a href="#ref-66">66</a></sup>. In response to worm or allergen challenge, IL-13Rα1-deficient animals had decreased expression of characteristic matrix remodeling genes and collagen deposition in their livers<sup><a href="#ref-66">66</a></sup> and profibrogenic mediators such as TGF-β in their lungs<sup><a href="#ref-64">64</a></sup>. However, recent studies highlight a protective role for IL-13Rα1 in regulating fibrosis in a bleomycin-induced injury murine model. Karo-Atar <i>et al</i>. demonstrated that IL-3Rα1 deficiency resulted in a dysregulation in homeostasis and increased fibrosis due to exaggerated tissue repair<sup><a href="#ref-67">67</a></sup>. Although bleomycin-elicited lung inflammation and injury is not a typical allergic inflammatory response, these results suggest a role for the IL-13Rα1 as a sink for excess cytokine during the wound-healing response. This role could also be important in allergic inflammation, since IL-13Rα1-deficient mice have increased circulating IL-13 and soluble IL-13Rα2<sup><a href="#ref-64">64</a></sup>. Another interesting study demonstrated that the integrin Mac-1 binds to IL-13Rα1 to downregulate macrophage IL-13 signaling, M2 polarization, and foam cell formation<sup><a href="#ref-68">68</a></sup>. Macrophages from the Mac-1-deficient mice had elevated M2 polarization, even in the absence of IL-13. Whether low Mac-1 expression could contribute to the abundance of M2 macrophages in asthmatic lungs is unknown. This work suggests that the interaction between Mac-1 and IL-13Rα1 may be exploited for the regulation of IL-13 signaling and M2 polarization of macrophages in the lung.</p><p class="" id=d7202e556>Because IL-13R (type II IL-4R) mediates the effects of IL-13 on structural (non-hematopoietic) cells, the clinical efficacy of a number of antibodies directed against IL-13 (IMA-638, IMA-026) has been evaluated in asthma. The results have been mixed. First, Wyeth evaluated the efficacy of two separate humanized anti-IL-13 IgG1 monoclonal antibodies (IMA-638 [NCT00339872]; IMA-026 [NCT00725582]) in asthma clinical trials. Interestingly, after allergen exposure, only treatment with IMA-638, which recognizes the IL-13 epitope that interacts with IL-4Rα, significantly reduced both the early and the late-phase asthmatic response. On the other hand, IMA-026, which binds to the epitope on IL-13 that is critical for binding to both IL-13Rα1 and IL-13Rα2, efficacious<sup><a href="#ref-69">69</a></sup>. Similarly, a more recent clinical trial utilizing another anti-IL-13 IgG1 monoclonal antibody (GSK679586, GlaxoSmithKline), which interferes with binding of IL-13 to both IL-13Rα1 and IL-13Rα2, did not result in any benefit in severe asthmatic patients over placebo controls<sup><a href="#ref-70">70</a></sup>. Thus, it appears that blocking the interaction of IL-13 with IL-4Rα may be more effective than inhibiting binding to either IL-13Rα1 or IL-13Rα2.</p><p class="" id=d7202e567>Based on the inconsistent results of the previous studies, a study was designed to compare the effects of blocking IL-13 in asthma patients who were pre-identified as exhibiting an IL-13 signature <i>in vivo</i><sup><a href="#ref-70">70</a></sup>. In this randomized, double-blind trial of asthmatic patients with poorly controlled disease, patients were stratified into either Th2-high or -low subgroups based on their baseline Th2 status (IgE levels, blood eosinophil counts, and periostin) and treated subcutaneously with either placebo or 200 mg of the humanized IgG4 anti-IL-13 monoclonal lebrikizumab (Genentech, NCT00930163). Even in the presence of steroid treatment, lebrikizumab treatment resulted in an improvement in FEV1 in patients with a Th2-high phenotype but had no significant impact on FEV1 in patients with a Th2-low phenotype. These results demonstrate that blocking IL-13 in patients with a documented IL-13 signature may provide significant clinical benefit. As steroid treatment may have complicated the interpretation of the effects of IL-13 inhibition in the original study, a subsequent phase II randomized, double-blind, placebo-controlled study of lebrikizumab (NCT00971035) in asthmatic patients not receiving inhaled corticosteroids was conducted<sup><a href="#ref-71">71</a></sup>. In this study, lebrikizumab treatment did not show significant improvement in disease (pre-bronchodilator FEV1 values), despite effectively inhibiting Th2 biomarkers (IgE levels and exhaled nitric oxide [FeNO]). Surprisingly, these results suggest that IL-13 blockade may be effective in the context of steroid treatment but may not block disease in patients with mild disease (non-steroid dependent). Phase III studies are underway which should provide further clarification of the potential utility of IL-13 blockade in patients with uncontrolled asthma.</p></div><div class=section><a name=d7202e581 class=n-a></a><h3 class=section-title>IL-13Rα2</h3><p class="" id=d7202e586>IL-13Rα2 was previously described as a decoy receptor that counteracted IL-13-mediated signaling<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup> owing to its negligible cytoplasmic domain. Although IL-13Rα2 does not have a signaling domain, recent studies have shown that IL-13Rα2 engages with TMEM219 and that this interaction also contributes to the decoy function of IL-13Rα2<sup><a href="#ref-74">74</a></sup>. However, several lines of evidence suggest that the role of IL-13Rα2 in regulating inflammation may be more complex. For example, Fichtner-Feigl <i>et al</i>. reported that signaling through this receptor was involved in TGF-β1 production<sup><a href="#ref-75">75</a></sup> and activation of the mitogen-activated protein kinase (MAPK) pathway<sup><a href="#ref-76">76</a></sup>. Consistent with a role for IL-13Rα2 in promoting allergic inflammation, Chen <i>et al</i>. reported that allergen-driven AHR and eosinophilic inflammation were attenuated, rather than enhanced, in IL-13Rα2-deficient mice<sup><a href="#ref-77">77</a></sup>. Normal allergic inflammatory responses were restored by lung epithelial overexpression of membrane IL-13Rα2 in IL-13Rα2-deficient mice, suggesting that membrane-bound and soluble forms of IL-13Rα2 may mediate different functions. Supporting a positive role for IL-13Rα2 in asthma is the recent finding that sputum levels of IL-13Rα2 are associated with poor lung function, Th2 cell gene expression, and airway obstruction in the airways of asthmatics<sup><a href="#ref-78">78</a></sup>. Collectively, these studies suggest that IL-13Rα2 is an important regulator of IL-13-mediated responses: the directionality of its effects are likely dependent upon whether it is found in a soluble or membrane-bound form. Lastly, as will be discussed below, IL-13Rα2 has been shown to have other binding partners besides IL-13, such as chitinase 3-like 1 (Chi3l1)<sup><a href="#ref-74">74</a></sup>. The complex role of IL-13Rα2 in regulating IL-13-mediated signals suggests that approaches to inhibit IL-13 could be a double-edged sword depending on whether or not they impact the ability of IL-13Rα2 to bind IL-13, which might result in the loss of the inhibitory functions of IL-13Rα2.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e631>New twists on IL-4 and IL-13 signaling pathways</h2><p class="" id=d7202e634>Canonical signaling of IL-4 and IL-13 results in signal transducer and activator of transcription (STAT)6 phosphorylation and transcriptional activation of STAT6-dependent genes<sup><a href="#ref-79">79</a></sup>. However, STAT6signaling in response to IL-4 and IL-13 does not always explain all features of Th2-mediated inflammation. A second pathway that is differentially activated by IL-4 and IL-13 could explain some of the subtleties between the two cytokines. Specific activation of both IL-4R complexes by either IL-4 or IL-13 can also trigger insulin receptor substrate (IRS)-2 activation. IRS activation results in the growth-promoting, proliferative effects of IL-4 as well as activating the AKT target of rapamycin (TOR) pathway and gene expression downstream. However, the difference lies in the magnitude of IRS-2 activation by IL-4 compared to IL-13. IL-4 engagement of IL-4R type I triggers IRS-2 activation particularly robustly, significantly enhancing IL-4-induced responses such as M2 macrophage polarization over that elicited by IL-13<sup><a href="#ref-79">79</a>,<a href="#ref-80">80</a></sup>. This was due to the presence of the γc chain in type I IL-4R complexes that is not found in the type II IL-4R. Thus, IRS-2 was concluded to be an amplifier of IL-4-induced M2 macrophage polarization, yet new evidence suggests a more complex role for the IRS-2 molecule. The absence of IRS-2 increased IL-4-induced M2 gene expression in murine bone-marrow-derived macrophages and stronger allergic lung inflammation <i>in vivo</i>. This novel regulatory role for IRS-2 was STAT6 independent<sup><a href="#ref-81">81</a></sup> and suggests that IRS-2 activation may participate in a negative feedback inhibitory loop through the TOR complex to decrease IL-4 signaling. This will be discussed further in the metabolism section of this review.</p><p class="" id=d7202e655>In contrast, when IL-4-induced IRS-2 activation was prolonged through knockdown of the negative regulator suppressor of cytokine signaling (SOCS)1 <i>in vitro</i>, enhanced<i></i> M2 polarization of human monocytes was observed<sup><a href="#ref-82">82</a></sup>. Furthermore, dysregulation of IRS-2 signaling in monocytes from allergic asthmatics was associated with increased M2 macrophage polarization owing to the lack of SOCS1 induction and increased SOCS3 expression<sup><a href="#ref-82">82</a></sup>. SOCS3 was also highly induced in M2 macrophages at the site of contact hypersensitivity (CHS) to control MMP-12 expression and CHS pathology<sup><a href="#ref-83">83</a></sup>. Taken together, differential expression of SOCS1 and SOCS3 in healthy versus inflammatory conditions suggests that an important balance exists between these molecules to maintain homeostasis in macrophages. A similar paradigm exists in T cells. SOCS3 and SOCS5 are mainly expressed in Th2 and Th1 cells, respectively, and reciprocally inhibit Th1 and Th2 differentiation<sup><a href="#ref-84">84</a></sup>. When dysregulation of the balance between different SOCS proteins occurs, pathological Th2 or M2 polarization results. Numerous examples of dysregulation of SOCS expression in eosinophils<sup><a href="#ref-85">85</a></sup>, airway smooth muscle<sup><a href="#ref-86">86</a></sup>, skin<sup><a href="#ref-87">87</a></sup>, and T cells<sup><a href="#ref-88">88</a></sup> have been documented in allergic inflammation. Single nucleotide polymorphisms (SNPs) in the SOCS1 promoter are associated with adult asthma and total serum IgE in children<sup><a href="#ref-89">89</a></sup>. Hence, restoring SOCS function to ameliorate inflammatory conditions could be considered as a future therapeutic strategy for asthma, as it has been in the setting of autoimmunity<sup><a href="#ref-90">90</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e708>Downstream regulation of allergic inflammation</h2><p class="" id=d7202e711>IL-4 and IL-13 activation of their receptors on a variety of structural and hematopoietic cells leads to the transcription of a wide variety of mediators, which mediate the pathophysiological manifestations of allergic disease, several of which have recently received considerable attention.</p><div class=section><a name=d7202e714 class=n-a></a><h3 class=section-title>Chitinases</h3><p class="" id=d7202e719>Several chitinase (chitin-degrading enzymes) genes are induced by type-2 cytokines in humans and mice including AMCase, YKL-40 (Chi3l1), breast regression protein (BRP)-39, and YM1/2 in mice<sup><a href="#ref-91">91</a></sup>.<i><b><i></i></b></i> Chitin is a highly abundant polysaccharide in nature and is an essential component of many organisms that drive type-2 immune responses (fungi, arthropods [house dust mites, crabs, and shrimp], and parasites). The functions of chitin are highly dependent upon its size: chitin has been shown to induce eosinophilic lung infiltration<sup><a href="#ref-92">92</a></sup> and elicit IL-33 production from epithelial cells<sup><a href="#ref-93">93</a>,<a href="#ref-94">94</a></sup>. The role of AMCase, the only IL-13-induced chitinase with chitinase enzymatic activity, in asthma has been conflicting<sup><a href="#ref-95">95</a></sup>. In contrast, many, but not all, studies suggest that YKL-40 is increased in severe asthma and/or neutrophilic asthma<sup><a href="#ref-96">96</a></sup>. Epithelial cells are thought to be the primary producers of YKL-40, and mechanical stress has been shown to be a trigger of YKL-40 secretion through an epidermal growth factor receptor (EGFR)- and MEK1/2-dependent pathway<sup><a href="#ref-97">97</a></sup>. YKL-40 has been reported to regulate a number of functions in the lung including IL-8 production<sup><a href="#ref-98">98</a></sup>, MUC5AC production<sup><a href="#ref-99">99</a></sup>, and the proliferation of bronchial smooth muscle cells<sup><a href="#ref-100">100</a></sup>. Recent studies demonstrated that the mouse homolog of YKL-40, Chi3l1, binds to and signals via IL-13Rα2. The same group later demonstrated that the membrane protein TMEM219 is a binding partner of IL-13Rα2. Interestingly, blockade of TMEM219 or IL-13Rα2 phenocopied one another in their ability to decrease Chi3l1-stimulated epithelial cell HB-EGF production, macrophage MAPK/ERK and protein kinase B (PKB)/AKT activation, oxidant-induced apoptosis, and lung injury. These studies demonstrate that an important regulatory loop exists among IL-13, Chi3l1, and IL-13Rα2, although the precise role of these interactions in asthma pathogenesis remains to be determined.</p></div><div class=section><a name=d7202e767 class=n-a></a><h3 class=section-title>FIZZ1</h3><p class="" id=d7202e772>Although FIZZ1 (<i>Retnla</i>) was identified as a marker of Th2 inflammation<sup><a href="#ref-101">101</a>,<a href="#ref-102">102</a></sup>, recent reports suggest the opposite. The increase in abundance of FIZZ1 in allergic diseases was interpreted as promoting Th2 responses<sup><a href="#ref-101">101</a>,<a href="#ref-103">103</a></sup>, yet Lee <i>et al</i>. demonstrated that overexpression of FIZZ1 did not induce alterations in lung histology and lung function. In contrast, <i>Retnla</i>-overexpressing mice exhibited a reduction in lung inflammation following allergen sensitization and challenge<sup><a href="#ref-104">104</a></sup>. This new evidence suggests a negative regulatory role for FIZZ1, agreeing with studies showing that mice lacking FIZZ1 developed exacerbated lung inflammation after <i>Schistosoma mansoni</i> (Sm) eggs challenge compared with their wild-type counterparts<sup><a href="#ref-105">105</a></sup>. Therefore, the elevated expression of FIZZ1 appears to mediate negative regulation of Th2 inflammation in the lung.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e815>New pathways regulating type-2 cytokine production</h2><p class="" id=d7202e818>Activation of the Th2 pathway is initiated from a complex interaction between the innate and adaptive immune responses. Although the critical role of antigen-presenting cell interactions with CD4<sup>+</sup> T cells in the differentiation of naïve T cells into type-2 cytokine-producing cells has long been appreciated,new information is emerging regarding the complex regulation of DC–T cell interactions that result in Th2 immune responses. Moreover, our understanding of the role of epithelial-derived cytokines in the direction of Th2 differentiation and in the regulation of non-T cell sources (ILC2s) of type-2 cytokines is rapidly expanding.</p><div class=section><a name=d7202e824 class=n-a></a><h3 class=section-title>DC–T cell interactions</h3><p class="" id=d7202e829>Antigen presentation to naïve T cells is an essential step in the development of adaptive immune responses. Recent studies have identified a member of the tumor-associated macrophage (TAM) family receptor tyrosine kinase, TYRO3, as an important negative regulator of DC–T cell interactions and consequently the magnitude of type-2 immune responses<sup><a href="#ref-106">106</a></sup>. Specifically, TYRO3-deficient mice or neutralization of its orthologue in human DCs resulted in the enhancement of type-2 immunity. Interestingly, the TYRO3 agonist protein S1 (PROS1) is specifically induced in CD4<sup>+</sup> Th2 cells by IL-4. PROS1, in turn, ligates the rheostat TYRO3 on PDL2<sup>+</sup> DCs to limit the intensity of type-2 responses. Importantly, multiple intronic variants in TYRO3 were associated with asthma<sup><a href="#ref-106">106</a></sup>. Modulation of this self-limiting process intrinsic to type-2 immunity provides a novel opportunity to inhibit allergic responses.</p><p class="" id=d7202e846>Little is known about the signals from DCs that drive Th2 immune responses. New studies show that specific subsets of DCs may contribute to this process. Gao <i>et al</i>. have shown that PDL2<sup>+</sup> DCs are able to enhance proliferation and cytokine production by effector and memory CD4<sup>+</sup> T cells, but not in naïve cells, compared with PDL2<sup>–</sup> DCs<sup><a href="#ref-107">107</a></sup>. Other studies using <i>in vivo</i> depletion approaches have demonstrated an important role for CD301b<sup>+</sup> but not for CD207<sup>+</sup> dermal DCs in driving Th2 differentiation in both OVA-specific transgenic CD4<sup>+</sup> T cells and during infection with <i>Nippostrongylus brasiliensis</i><sup><a href="#ref-108">108</a></sup>. These novel studies suggest that depletion/inhibition of specific DC subsets is a potential therapeutic approach to suppress the initiation of Th2 immune responses.</p></div><div class=section><a name=d7202e885 class=n-a></a><h3 class=section-title>T cell receptor regulation</h3><p class="" id=d7202e890>T cells play a determinant role in adaptive responses. They are able to recognize an infinite diversity of antigens through the T cell receptor (TCR) with concomitant activation of the T cell<sup><a href="#ref-109">109</a></sup>. As mentioned above, different polarized T helper cell environments participate in the different asthma phenotypes, highlighting the importance of T cell subset differentiation in allergic inflammation. Few T cell intrinsic factors have been identified which govern Th2 differentiation. Newly described mechanisms have been identified that downregulate TCR signaling specifically in Th2 cells. DENND1B, a guanine nucleotide exchange factor<sup><a href="#ref-110">110</a></sup>, downmodulates TCR expression in Th2 cells. Yang <i>et al</i>. demonstrated that <i>in vitro</i>-differentiated Dennd1b<sup>–/–</sup> Th2 cells have increased TCR-mediated responses when compared to Dennd1b<sup>+/+</sup> Th2 cells without changes in Th1 or Th17 responses. This specific effect on Th2 cells may be due to a delayed surface TCR downmodulation upon activation, resulting in increased TCR signaling. This appears to have direct relevance to asthma, as SNPs at the human DENND1B locus have been associated with increased Th2 responses and asthma in young children<sup><a href="#ref-111">111</a></sup>.</p></div><div class=section><a name=d7202e919 class=n-a></a><h3 class=section-title>E3 ubiquitin ligase regulation of Th2 cells</h3><p class="" id=d7202e924>Recent studies suggest that E3 ubiquitin ligases are critical regulators of T cell activation and cytokine production. For example, overexpression of <i>Grail</i>, an E3 ubiquitin ligase, has been associated with suppressed IL-2 and IL-4 production in T cells<sup><a href="#ref-112">112</a></sup>. Mechanistically, <i>Grail</i> regulates Th2 cytokine production by interacting with STAT6, targeting it for ubiquitination and degradation. Accordingly, <i>Grail</i>-knockout mice are more susceptible to allergen-driven asthma<sup><a href="#ref-113">113</a></sup>. Another E3 ubiquitin ligase, casitas B cell lymphoma (Cbl)-b, which is involved in regulating CD28 signal strength during TCR ligation, has also been shown to be important in the regulation of allergic inflammation<sup><a href="#ref-114">114</a></sup>. Cbl-b-deficient mice have enhanced Th2 cytokine production and delayed resolution of allergen-induced airway inflammation. Interestingly, no changes in IgE levels were noted. Modulation of this class of molecules may provide a unique approach to asthma therapy.</p></div><div class=section><a name=d7202e951 class=n-a></a><h3 class=section-title>Th17 pathway regulation of Th2-mediated inflammation</h3><p class="" id=d7202e956>In addition to the prototypical Th2 cytokines, other previously unrelated cytokines, such as IL-17, have now been demonstrated to modulate Th2 immune responses. Understanding the molecular mechanism(s) of IL-17’s modulatory role in Th2 responses is of interest, since “mixed” Th2/Th17 T cell populations are present in some asthmatic patients <i>in vivo</i><sup><a href="#ref-115">115</a>,<a href="#ref-116">116</a></sup>. Co-exposure of mice to IL-13 and IL-17 enhanced all aspects of the allergic phenotype compared to IL-13 treatment alone<sup><a href="#ref-115">115</a></sup>. This was associated with an IL-17-mediated increase in IL-13-induced STAT6 activation in both mouse fibroblasts and primary human nasal epithelial cells (NECs)<sup><a href="#ref-117">117</a></sup>. Conversely, specific suppression of Th2 cytokines in the house dust mite (HDM) model of allergic asthma enhanced Th17 responses, and “Th2-high” and “Th17-high” disease was mutually exclusive in some asthmatic patients<sup><a href="#ref-118">118</a></sup>. These contradictory studies highlight that the exact mechanism(s) dictating the balance between Th2 and Th17 responses remain unclear. Careful immunophenotyping of patients prior to IL-17- or IL-4-/IL-13-based therapies will be essential, as disturbance of the Th2/Th17 balance may worsen the disease in some individuals. Blockade of IL-17RA with brodalumab, a human anti-IL-17RA monoclonal antibody, in subjects with inadequately controlled moderate-to-severe asthma taking regular inhaled corticosteroids did not have a significant impact on asthma. However, there was a positive effect on the asthma control questionnaire score in the high-reversibility subgroup (post-bronchodilator FEV1 improvement &gt;20%)<sup><a href="#ref-119">119</a></sup>. As the significance of this effect is currently not known, further studies are required to unravel the complexities of the contribution of IL-17 to asthma pathogenesis.</p></div><div class=section><a name=d7202e985 class=n-a></a><h3 class=section-title>IL-31</h3><p class="" id=d7202e990>IL-31 is constitutively expressed by non-hematopoietic cells such as the lung epithelium and is also selectively produced by activated CD4<sup>+</sup> T cells skewed towards Th2 cytokine production<sup><a href="#ref-120">120</a></sup>. IL-31RA is a gp130-like type-1 cytokine receptor that pairs with OSMRB to form a functional signaling receptor for IL-31. IL-4 and IL-13 increase the expression of the membrane-bound form of IL-31RA through the type II IL-4R, altering IL-31-mediated signaling in macrophages. IL-31 has been shown to be elevated in Th2-mediated diseases such as atopic dermatitis<sup><a href="#ref-121">121</a></sup> and is positively associated with asthma severity<sup><a href="#ref-122">122</a></sup>. Consistent with a role for IL-31 in asthma, Yu <i>et al.</i> showed that SNPs in IL-31 were significantly correlated with total serum levels of IgE in patients with asthma<sup><a href="#ref-123">123</a></sup>. Despite the preponderance of evidence suggesting that IL-31 promotes type-2 inflammation, Perrigoue <i>et al</i>. showed that IL-31R activation limited the magnitude of Th2 cytokine-dependent inflammatory responses to intestinal helminth infection<sup><a href="#ref-124">124</a></sup>. Taken together, these studies highlight important interactions between Th2 cytokines and IL-31 signaling pathways; however, further studies are needed to delineate the exact role that IL-31 plays in mediating type-2 immune responses and whether this will be a useful target for therapy in type-2-high asthmatics.</p></div><div class=section><a name=d7202e1024 class=n-a></a><h3 class=section-title>Alarmins as initiators of type-2 inflammation</h3><p class="" id=d7202e1029>Although Th2 cytokine production has long been recognized as a pivotal contributor to allergic inflammation, the mechanisms initiating Th2 cell differentiation and cytokine production has long eluded investigators. Recent studies have identified several epithelial-derived molecules such as thymic stromal lymphopoietin (TSLP), IL-25, and IL-33 as early initiators of Th2 inflammation in both mice and humans. These cytokines have been described as "epithelial-derived alarmins" that activate and potentiate the innate and humoral arms of the immune system in response to cellular damage. Each of the three epithelial-derived alarmins has been implicated in the pathophysiology of allergic asthma. A better understanding of the roles that these epithelial-derived alarmins play in disease and how they influence airway immune responses may allow the development of novel therapeutics for asthma treatment.</p><p class="" id=d7202e1032><b><i>TSLP.</i></b> The role of TSLP in allergic lung inflammation has garnered considerable interest. Early studies of mice overexpressing TSLP in airway epithelial cells resulted in spontaneous lung inflammation, enhanced eosinophilia, goblet cell metaplasia, perivascular fibrosis, and AHR<sup><a href="#ref-125">125</a></sup>. Moreover, Han and colleagues found that overexpression of TSLP in the lung induced an alternatively activated phenotype in pulmonary macrophages and increased BAL cell recruitment<sup><a href="#ref-126">126</a></sup>. Support for a role for TSLP was confirmed in studies utilizing <i>Tslpr</i><sup>–/–</sup> mice in a model of lung inflammation<sup><a href="#ref-127">127</a></sup>. Interestingly, TSLP effects were not direct but were dependent on IL-13<sup><a href="#ref-126">126</a></sup>. Consistent with the mouse studies, therapeutic antibody blocking of TSLP resulted in a reduction of lung eosinophils in a cynomolgus monkey model of allergic lung inflammation<sup><a href="#ref-128">128</a></sup>. TSLP also synergizes with IL-25 and IL-33 to promote inflammation and lung fibrosis induced by <i>Schistosoma</i>. Only antibody blockade of all three cytokines suppressed Th2-mediated fibrosis, although this approach did not work in a model of chronic HDM-induced allergic lung inflammation<sup><a href="#ref-129">129</a></sup>. These results suggest that fibrosis may be induced in the lung through multiple pathways. TSLP seems to play a more important role in the gut, where it is constitutively expressed in both mice and humans. In the gastrointestinal tract, TSLP is not only an important enhancer of inflammatory Th2 responses<sup><a href="#ref-130">130</a>–<a href="#ref-132">132</a></sup> but also a key player in the maintenance of homeostasis by controlling inflammatory responses against parasites<sup><a href="#ref-133">133</a>–<a href="#ref-137">137</a></sup> and Th1 and Th17 responses<sup><a href="#ref-138">138</a>,<a href="#ref-139">139</a></sup>. Therefore, the function of TSLP is complex, both promoting and controlling inflammation in a tissue-dependent manner. Support for a role for TSLP in human disease has recently been provided in a study of a human anti-TSLP monoclonal antibody (AMG 157), which binds TSLP and prevents receptor interaction. In a double-blind, placebo-controlled study, AMG 157 attenuated both early and late allergen-induced bronchoconstriction and indices of airway inflammation in allergic asthmatic subjects<sup><a href="#ref-140">140</a></sup>. Although these results are promising, further studies are required.</p><p class="" id=d7202e1097><b><i>IL-25.</i></b> IL-25, also named IL-17E, is a cytokine able to enhance Th2 immune responses. It was first described as a product of “highly polarized” murine Th2 cells in the presence of IL-4/anti-IL-12 monoclonal antibodies<sup><a href="#ref-141">141</a></sup>. However, more recent studies indicate that IL-25 can be produced by a great variety of cells including eosinophils, basophils, mast cells, macrophages, epithelial cells, and Tuft cells, among others<sup><a href="#ref-142">142</a></sup>, highlighting its importance as an initiator of Th2 responses. For example, during <i>N. brasiliensis</i> infection, hyperplasia of Tuft cells—the only IL-25-releasing cell—occurs in the small intestine. A feed-forward system mediated through IL-25 release by Tuft cells activates ILCs to release IL-13, which in turn regulates the number of Tuft cells<sup><a href="#ref-143">143</a></sup>. Interestingly, Tuft cells express taste receptors such as bitter and umami receptors, which are G-protein-coupled receptors (GPCRs), that participate in the release of acetylcholine when activated<sup><a href="#ref-144">144</a></sup>. This has been associated with changes in nutrient and metabolite levels in the gut lumen, which could help Tuft cells detect danger signals, such as the presence of helminths<sup><a href="#ref-145">145</a></sup>, and initiate a protective Th2 immune response. The signaling and functional responses to helminths at the gut epithelial barrier show remarkable similarity to the lung in that bitter taste receptors and early alarmin signaling may work together to coordinate the immune response to inhaled antigens. Blockade of the IL-25 receptor, IL-17RA, in bronchial rings from donors with asthma significantly reduced acetylcholine-induced contraction compared to that seen in donors without asthma<sup><a href="#ref-146">146</a></sup>. One of the major triggers of asthma exacerbations, rhinovirus infection, was shown to induce significantly greater expression of IL-25 mRNA expression in bronchial epithelial cells from asthmatics compared to those in non-atopic, non-asthmatic healthy individuals<sup><a href="#ref-147">147</a></sup>. Although these studies suggested that blocking IL-17RA in asthma might be promising, studies with the anti-IL-17RA monoclonal antibody brodalumab have failed to show benefit in asthma<sup><a href="#ref-119">119</a></sup>, implying that blocking IL-25 alone is insufficient to modify disease.</p><p class="" id=d7202e1139><b><i>IL-33.</i></b> Another alarmin that has risen to prominence in recent years is IL-33, a novel cytokine discovered almost 10 years ago<sup><a href="#ref-148">148</a></sup>. The importance of IL-33 in allergic disease was initially identified through a genome-wide association study (GWAS). The GABRIEL consortium, the largest GWAS meta-analysis involving more than 26,000 subjects, demonstrated significant association between asthma and a SNP (rs1342326) on chromosome 9 flanking the <i>IL33</i> gene. Polymorphisms in the <i>IL33</i> gene were among the top three SNPs to correlate with asthma<sup><a href="#ref-149">149</a></sup>. Similarly, strong associations between variants of the gene encoding the unique IL-33 receptor, suppression of tumorigenicity (<i>ST2</i>) or <i>IL1RL1</i>, and asthma risk have been observed<sup><a href="#ref-150">150</a></sup>. The identification of IL-33 and its receptor as asthma susceptibility genes has opened up a fruitful new field of study that has exponentially increased our understanding of the mechanisms driving aberrant type-2 immune responses.</p><p class="" id=d7202e1171>IL-33 has been shown to be an important regulator of type-2 cytokine production and the pathogenesis of allergic diseases. In several mouse models of asthma, IL-33 activates lung-resident ILC2s and initiates airway type-2 inflammation<sup><a href="#ref-20">20</a>,<a href="#ref-151">151</a></sup>. Similarly, administration of rIL-33 to mice through a variety of routes resulted in tissue eosinophilia, goblet cell hyperplasia, and elevations in type-2 cytokines<sup><a href="#ref-152">152</a></sup>. The timing of expression of IL-33 in the lung is thought to be critically important to the development of skewed Th2 immune responses. It has been reported that shortly after birth, ILC2s, eosinophils, basophils, and mast cells spontaneously accumulate in the developing lung in an IL-33-dependent fashion<sup><a href="#ref-153">153</a></sup>. Upon encounter with allergens during early lung development, the changes are further boosted, promoting Th2 cell skewing. Thus, enhanced neonatal Th2 cell skewing in response to exposure to inhaled allergens results from postnatal hyper-responsiveness of the IL-33 axis during a period of maximal lung remodeling.</p><p class="" id=d7202e1189>IL-33 is a member of the IL-1 family of cytokines, which is constitutively expressed in the nucleus of a variety of cells in both mice and humans<sup><a href="#ref-148">148</a></sup>. Because of its localization within the nucleus, it is thought to function as a nuclear receptor, although its exact function in the nucleus is unknown. In addition to potential nuclear functions, IL-33 is released primarily from endothelial and epithelial cells and binds its functional receptor on a variety of cells, including mast cells, eosinophils, and ILC2s<sup><a href="#ref-154">154</a></sup>. Unlike other IL-1 family members, IL-33 does not require cleavage by caspase 1 for release from the cell or to initiate signaling via ST2<sup><a href="#ref-155">155</a></sup>; however, it can be inactivated by either caspase-3 or caspase-7. On the other hand, cleavage by extracellular proteases (chymase and tryptase), commonly produced by inflammatory cells such as mast cells present during allergic reactions, results in three major forms of “mature” IL-33. These cleaved versions of IL-33 are up to 30-fold more potent as activators of ILC2s <i>ex vivo</i> compared with full-length human IL-33<sup><a href="#ref-156">156</a></sup>.</p><p class="" id=d7202e1211>Despite the importance of IL-33 to the initiation of an allergic response at mucosal surfaces, the molecular mechanisms responsible for its expression and extracellular release are poorly understood. IL-33 transcription is believed to be initiated from one of two non-coding exons that are associated with constitutive or induced production of IL-33<sup><a href="#ref-157">157</a></sup>. A recent study suggested that the RNA-binding protein Mex-3B regulates IL-33 expression in airway epithelial cells via binding to the IL-33 3' UTR and increasing IL-33 expression by inhibiting miR-487b-3p-mediated repression of IL-33<sup><a href="#ref-158">158</a></sup>. The importance of Mex-3B to the regulation of IL-33 in allergic inflammation is demonstrated in Mex-3B-deficient mice, which are protected against allergen-induced airway inflammation due to the induction of IL-33. Moreover, it was shown that inhalation of an anti-sense oligonucleotide targeting Mex-3B suppressed the development of allergic airway inflammation in mice.</p><p class="" id=d7202e1222>As IL-33 lacks a traditional signal sequence<sup><a href="#ref-159">159</a></sup>, it was originally thought to be released primarily by damaged or necrotic cells<sup><a href="#ref-160">160</a></sup>. However, a more complex picture is emerging in which it can be released from both human and mouse living cells both constitutively and following exposure to a variety of stimuli<sup><a href="#ref-161">161</a>,<a href="#ref-162">162</a></sup>. Under homeostatic conditions, pools of IL-33 become active locally to sustain basal physiology by activating ST2<sup>+</sup> cells. In response to a number of perturbations, such as allergen exposure, it can be induced through multiple pathways in the absence of cell death depending on the nature of the stimulus. For example, common allergens such as <i>Alternaria alternata</i> and HDM induce IL-33 secretion through a mechanism dependent on DUOX-1-mediated activation of the epithelial EGFR and the protease calpain-2 through a redox-dependent mechanism involving cysteine oxidation of the EGF and the tyrosine kinase Src<sup><a href="#ref-163">163</a></sup>. Consistent with the importance of this pathway to allergic disease, NECs from allergic asthmatic patients were shown to express more DUOX-1 and IL-33 compared to non-asthmatic individuals. Several studies also suggest that extracellular ATP can induce the secretion of IL-33<sup><a href="#ref-164">164</a></sup>. Alternative splicing resulting in cytoplasmic IL-33 has also been proposed as a potential mechanism of extracellular release<sup><a href="#ref-165">165</a></sup>. Consistent with these findings, splice variants of human <i>IL33</i> have been recovered from primary cells; however, the physiological relevance of these variants is currently unknown<sup><a href="#ref-166">166</a></sup>. IL-33 is clearly a key player in the initiation of allergic inflammation, suggesting that it would be an excellent target for biologic therapy. However, as it also plays a role in other non-Th2-mediated inflammatory diseases<sup><a href="#ref-167">167</a>,<a href="#ref-168">168</a></sup>, a more detailed understanding of the plethora of IL-33’s actions is required prior to targeting it in allergic individuals.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e1277>Impact of cellular metabolism on Th2-mediated inflammation</h2><p class="" id=d7202e1280>In recent years, the role of metabolism in regulating the function of immune and non-immune cells that are important in asthma has been uncovered. Balancing nutrient utilization and metabolism is critical for cells to meet energy needs required to survive, proliferate, and perform their specific functions (i.e. cytokine secretion). A variety of metabolic mediators such as arginine, extracellular lactate, and cyclic adenosine monophosphate (cAMP)/ATP have been implicated in various aspects of the asthmatic phenotype. Recent evidence suggests that the integration of these metabolic functions, sensing of the external nutrient milieu, and immune cell polarization occurs through the PI3K/AKT/mammalian TOR (mTOR) pathways<sup><a href="#ref-169">169</a>,<a href="#ref-170">170</a></sup>. While the importance of immune cell metabolic remodeling in different physiological settings is not fully understood, there is a growing realization that inappropriate metabolic function underlies many aberrant immune responses and that reprogramming cellular metabolism may provide a therapeutic avenue to alter immunity<sup><a href="#ref-171">171</a>,<a href="#ref-172">172</a></sup>.</p><div class=section><a name=d7202e1297 class=n-a></a><h3 class=section-title>Arginine metabolism</h3><p class="" id=d7202e1302>Arginine is a key substrate in the citrulline–NO and tricarboxylic acid cycles. However, little is known about how mitochondrial arginine metabolism modulates inflammation. Elevated expression of the arginine-metabolizing enzymes iNOS and arginase were found in the airway epithelium of asthmatics. Xu <i>et al</i>. described a mechanistic role for arginine metabolism in asthma. Greater arginine flux increased oxidative metabolism in airway epithelium, resulting in lower STAT6 and hypoxia-inducible factor signaling, which are both important drivers of asthma<sup><a href="#ref-173">173</a></sup>. Arginase 1 is also a critical regulator of ILC2 metabolismin the lung. Elevated <i>ARG1</i> expression was noted specifically in ILC2s from the lung tissue of patients with COPD and idiopathic pulmonary fibrosis. Deletion of <i>Arg1</i> specifically in ILC2s resulted in the attenuation of type-2-mediated lung inflammation in mice due to diminished ILC2 proliferation and cytokine production. This work has shed new light on how arginine metabolism may influence allergic inflammatory responses<sup><a href="#ref-174">174</a></sup>. Since ILC2s are one of the major producers of the cytokines that initiate Th2 immune responses in allergic inflammation, the modulation of arginine metabolism may provide a promising avenue for the regulation of these low-frequency cells, thereby preventing the initiation of Th2 inflammation.</p></div><div class=section><a name=d7202e1323 class=n-a></a><h3 class=section-title>Lactate</h3><p class="" id=d7202e1328>Recent studies have demonstrated that lactic acid produced by tumor cells induces an M2-like polarization with enhanced <i>Arg1</i> expression in murine TAMs compared with peritoneal macrophages<sup><a href="#ref-175">175</a></sup>. Similarly, a recent study by Selleri <i>et al</i>. demonstrated that the presence of lactate during the differentiation of human monocytes to DCs induced a M2 macrophage phenotype. These M2 macrophages induced Th2 polarization. This effect was due to a decrease in oxidative phosphorylation, lower basal respiration, and more polarized mitochondrial membrane potential as well as higher spare respiratory capacity<sup><a href="#ref-176">176</a></sup>. This lactate-induced M2 phenotype is consistent with the lactic acidosis observed in patients with severe asthma<sup><a href="#ref-177">177</a>,<a href="#ref-178">178</a></sup> and the observation that asthmatics have more M2 macrophages in their lungs than do non-asthmatics<sup><a href="#ref-38">38</a>,<a href="#ref-179">179</a></sup>. Furthermore, lactic acid has been shown to delay NF-κB activation and suppress LPS-induced TNF-α secretion in monocytes, promoting an M2 macrophage phenotype<sup><a href="#ref-180">180</a>,<a href="#ref-181">181</a></sup>. However, opposite effects have been attributed to lactate, the salt form of lactic acid, in that it enhanced LPS-mediated inflammatory responses in macrophages<sup><a href="#ref-182">182</a></sup>. Recent studies have shown that lactic acid negatively regulates IL-33-mediated cytokine and chemokine production in murine bone-marrow-derived mast cells and primary human mast cells, resulting in the suppression of inflammation<sup><a href="#ref-183">183</a></sup>. Accordingly, lactic acid and lactate might be playing different roles in M2 polarization and asthma depending on the local pH. A better understanding of the conditions that induce either systemic or localized changes in airway pH may inform the development of more effective strategies to control asthma.</p></div><div class=section><a name=d7202e1376 class=n-a></a><h3 class=section-title>mTORC</h3><p class="" id=d7202e1381>mTOR complex (mTORC)-activated pathways have emerged as critical regulatory nodes for the polarization of T cells<sup><a href="#ref-184">184</a>,<a href="#ref-185">185</a></sup> and macrophages<sup><a href="#ref-186">186</a></sup>. The TORC1 pathway is crucial for the development of Th17 polarization in naïve murine T cells, but not the other Th profiles<sup><a href="#ref-187">187</a></sup>, linking the opposing regulation between Th2 and Th17 responses. This points to the mTOR pathway as a possible target for effective therapy to ameliorate Th2/Th17 mixed asthma phenotypes. Exploring the mTOR pathway for type-2-high asthmatics should be approached with caution, however, given the uncertainty surrounding equivocal data on the Th2/Th17 balance discussed above.</p><p class="" id=d7202e1399>Regulation of macrophage polarization following the TORC1/2 dichotomy established for T cells has been an attractive concept. IL-4-dependent M2 macrophage differentiation is associated with mTORC2/STAT6 activation and increased fatty acid oxidation and oxidative phosphorylation<sup><a href="#ref-188">188</a></sup>. In contrast, constitutive activation of mTORC1 due to myeloid-specific deletion of its negative regulator tuberous sclerosis complex 1 leads to decreased M2 macrophage polarization by attenuating IL-4-induced AKT activation and M2 gene expression<sup><a href="#ref-189">189</a>,<a href="#ref-190">190</a></sup>. This correlates with the novel role of TORC1-activated p70S6K1 and GRB10 as key negative regulators of IL-4-induced IRS-2 signaling and M2 macrophage polarization<sup><a href="#ref-191">191</a></sup>. The balance between mTORC1 and mTORC2 in controlling macrophage polarization was also highlighted by studies in mice with a myeloid-specific deletion of rapamycin-insensitive companion of mTOR, a subunit of mTORC2. Lacking functional mTORC2 resulted in exaggerated responses to LPS and other TLR ligands and decreased M2 macrophage markers<sup><a href="#ref-192">192</a></sup>. Taken together, these studies highlight the importance of mTOR complexes in dictating M2 polarization. In addition, they point to possible targets, such as p70S6K or GRB10, that could be used therapeutically to downmodulate IL-4-mediated inflammatory responses and M2 macrophage polarization and to control type-2-high asthma.</p></div><div class=section><a name=d7202e1423 class=n-a></a><h3 class=section-title>cAMP/ATP</h3><p class="" id=d7202e1428>cAMP also alters cellular phenotype. Bone-marrow-derived DCs from mice deficient in the production of cAMP triggered Th2 polarization of CD4<sup>+</sup> T cells. These mice developed spontaneous elevations in total IgE, resulting in severe Th2-mediated lung inflammation. Exposure to the cell-permeable cAMP analog 8-CPT-cAMP (CPT) decreased their ability to induce Th2 responses<sup><a href="#ref-193">193</a></sup>. However, the role of cAMP in inflammation is more complex and could be cell specific. Mucus production by bronchial epithelial cells depends not only on IL-13 stimulation but also on signaling through the β2-adrenoceptor (β2AR). New research shows that epinephrine activation of β2AR and ERK1/2, JNK, and cAMP signaling is necessary for mucin production. These findings may explain the side effects of chronic β2AR agonist use in asthma<sup><a href="#ref-194">194</a></sup>.</p><p class="" id=d7202e1442>In addition to cAMP, ATP has also been demonstrated to regulate inflammation. Through the utilization of a mouse model of OVA-induced lung inflammation, it was demonstrated that the P2X4 receptor (P2X4R) was upregulated in inflamed mouse lungs. Moreover, through binding to P2X4R, ATP enhanced the expression of α-smooth muscle actin<sup><a href="#ref-195">195</a></sup> and proliferating cell nuclear antigen<sup><a href="#ref-196">196</a></sup> in the lungs of allergically challenged mice. Overexpression of these two proteins is an indicator of cell proliferation in asthma. Furthermore, P2X4R antagonists decreased cell recruitment and mucus production in OVA-challenged mice. Taken together with ATP’s role in IL-33 release mentioned above, these studies suggest an important role for ATP in the regulation of airway inflammation and airway remodeling<sup><a href="#ref-197">197</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e1461>The microbiome as a modifier of Th2 inflammation</h2><p class="" id=d7202e1464>There has been an increased appreciation of the role of the gut and lung microbiota in shaping the Th2 response in asthma. The beneficial effects of exposure to certain bacterial products at key times in immune system development have been demonstrated to reduce the development of asthma in epidemiological studies of infant breastfeeding, vaginal delivery, exposure to certain pets in the home<sup><a href="#ref-198">198</a>–<a href="#ref-200">200</a></sup>, the number of siblings in the home<sup><a href="#ref-201">201</a></sup>, and exposure to farm dust <i>in utero</i><sup><a href="#ref-202">202</a></sup>. Early life antibiotic use<sup><a href="#ref-203">203</a>,<a href="#ref-204">204</a></sup>, lack of breastfeeding<sup><a href="#ref-205">205</a></sup>, or cesarean birth<sup><a href="#ref-206">206</a></sup> are associated with an increased risk of developing asthma. While no specific pathogens have been associated with the protective effect of these exposures against disease, recent studies in human asthmatics have suggested that alterations in the diversity of the gut and lung microbiome may be associated with an increased risk of developing asthma<sup><a href="#ref-207">207</a>,<a href="#ref-208">208</a></sup>.</p><p class="" id=d7202e1507>In a recent study in which the effects of the gut microbiome were investigated at the level of genera, the relative abundance of <i>Lachnospiraceae, Veillonella, Faecalibacterium,</i> and <i>Rothia</i> were found to be decreased in the gut in the first<i></i> 100 days of life in children who later went on to develop atopic asthma<sup><a href="#ref-209">209</a></sup>. Of note, the differences in relative abundance of these genera were no longer present at 1 year of age. The contribution of these species to asthma pathogenesis was further demonstrated in an experimental mouse model. Asthma was induced in germ-free mice that were colonized with the gut microbiome of a child with severe atopic allergy and very low relative abundance of <i>Lachnospiraceae, Veillonella, Faecalibacterium,</i> and <i>Rothia.</i> The effect was reversed with supplementation with the four protective bacterial genera. If replicated, these findings would provide a strong basis for a causal link between these four bacterial genera and the development of atopic asthma. These results are consistent with multiple studies suggesting that there is a critical time period in early life when gut flora imbalances have the most influence on allergic inflammation<sup><a href="#ref-209">209</a>–<a href="#ref-211">211</a></sup>.</p><p class="" id=d7202e1536>Studies in experimental animal models have shed some light on the potential mechanism(s) by which the shifts in phylogenic groups condition the immune system. For example, an intriguing study showed that the susceptibility of newborn mice to the development of HDM-driven BAL eosinophilia and AHR was associated with a lung microbial pattern dominated by <i>Firmicutes</i> and gammaproteobacterial phyla<sup><a href="#ref-212">212</a></sup>. Interestingly, over the first few weeks of life, the balance of lung phyla shifted towards a dominant <i>Bacteroidetes</i> pattern. This shift in the lung microbiota was associated with a reduction in responsiveness to allergen exposure and an increase in the population of PD-L1-dependent T-regulatory cells. Thus, these studies suggest that the establishment of a <i>Bacteroidetes</i>-dominated airway microbial pattern early in life is required to populate the lung with T-regulatory cells which provide sustained protection against the development of aeroallergen-induced airway inflammation.</p><p class="" id=d7202e1552>Further support of the concept that gut colonization with <i>Bacteroidetes</i> is associated with protection against the development of the asthmatic phenotype was provided by a study in mice in which a high-fiber diet protected them from the aeroallergen-induced asthma phenotype, concomitant with a shift towards predominant gut colonization with <i>Bacteroidetes</i><sup><a href="#ref-212">212</a></sup>. The protection afforded by the high-fiber diet was mediated via short-chain fatty acid-induced alterations in bone marrow hematopoiesis characterized by enhanced generation of macrophage and DC precursors and subsequent recruitment to the lungs of DCs with an impaired ability to promote Th2-cell differentiation. Mechanistically, the authors showed that the effects of one of the short-chain fatty acids (propionate) on the asthma phenotype were mediated via the GPCR 41 (GPR41). These three products of the fermentation of dietary fiber are absorbed by the host, where they circulate and communicate with the immune system by binding to host cell receptors. Indeed, short-chain fatty acids, such as butyrate and acetate, have been shown to regulate mucosal T-regulatory cell differentiation and function<sup><a href="#ref-213">213</a></sup>. In humans, decreased fecal short-chain fatty acids at 3 months of age have been observed in subjects who went on to develop atopy and wheeze at 3 years of age, and germ-free mice inoculated with the microbiome of a child with atopic wheeze had lower levels of the short-chain fatty acid butyrate than did control mice<sup><a href="#ref-214">214</a></sup>.</p><p class="" id=d7202e1573>Taken together, these results suggest that diet and the gut microbiome shape the immunological environment in the lung and that a disrupted microbiota could possibly have detrimental effects. Importantly, these results suggest that microbiota-based interventions could be used to influence the likelihood of developing allergies. However, the timing of administration of such therapies is critical and would likely have to be given in the “window of opportunity” in early life to be effective. Further research is now required to fully dissect the role of the microbiome in disease and ultimately pave the way for the emergence of new therapeutic strategies in combating these conditions.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d7202e1579>Conclusion</h2><p class="" id=d7202e1582>A better understanding of both canonical and newly appreciated pathways of regulation of allergic inflammation will inform the development of strategies to better control asthma and its consequences in Th2-high asthmatics. The new players that we have discussed in this review, such as the role of epithelial-derived cytokines in type-2 cytokine production (TSLP, IL-25, and IL-33), the identification of novel ligands for the IL-13 receptor IL-13Rα2, the role of E3 ubiquitin ligases in T cell differentiation, and the role of cellular metabolism in type-2 immune responses, highlight the tremendous complexity of the pathways and feedback loops that regulate IL-4/IL-13 production, their receptors, their signaling pathways, and their downstream consequences (summarized in <a href="#f1">Figure 1</a>). Some of these effects are uncovered only in the setting of specific polymorphisms or the presence or absence of other host factors (age as well as gut and lung microbiome). An appreciation of this complexity reinforces the importance of careful phenotyping of asthma endotypes in each patient to direct the appropriate intervention. Our emerging understanding of the intricate web of factors that modify Th2 responses will provide new therapeutic avenues that could lead to the development of better, more effective strategies to treat and/or prevent this increasingly common disease.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12082/e3984baa-066f-48a9-89e6-6c8aaf1793f5_figure1.gif"><img alt="e3984baa-066f-48a9-89e6-6c8aaf1793f5_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12082/e3984baa-066f-48a9-89e6-6c8aaf1793f5_figure1.gif"></a><div class=caption><h3>Figure 1. Summary of the canonical Th2 pathway and “new spins” on the pathways that lead to allergic inflammation.</h3><p id=d7202e1598>Newly appreciated modifiers of Th2 inflammation, such as alarmins, environmental factors, and G-protein-coupled receptor pathways, are indicated and discussed further in the text. Question marks indicate that the role of these new players is not completely clear or that they have been reported to have an enhancing or reducing effect on the outcome measure depending on the publication. AKT, protein kinase B; cAMP, cyclic adenosine monophosphate; DENND1B, DENN domain-containing 1B; FIZZ1, found in inflammatory zone 1; GRB10, growth factor receptor bound protein 10; IL, interleukin; IL-13Rα1, interleukin-13 receptor α1; ILC2, type-2 innate lymphoid cells; IRS-2, insulin receptor substrate 2; mTORC, mammalian target of rapamycin complex; PI3-K, phosphoinositide 3-kinase; SNP, single nucleotide polymorphism; SOCS, suppressor of cytokine signaling; STAT6, signal transducer and activator of transcription 6; STUB1, STIPI homology and U-box-containing protein 1; TAS2R, taste 2 receptor; TGF-β, transforming growth factor-β; TH2, T helper type-2; TSLP, thymic stromal lymphopoietin; YKL-40, chitinase-3-like protein 1.</p></div></div></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d7202e1 class=n-a></a><h2 class=main-title id=d7846>Author contributions</h2><p class=metadata-entry><a name=d7202e110 class=n-a></a><p id=d7202e111> Mireya Becerra-Díaz wrote the review. Marsha Wills-Karp and Nicola M. Heller edited and provided helpful discussion.</p></p></div><div class=back-section><a name=d7202e1 class=n-a></a><h2 class=main-title id=d7850>Competing interests</h2><p class=metadata-entry><a name=d7202e114 class=n-a></a><p id=d7202e115> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d7202e1 class=n-a></a><h2 class=main-title id=d7852>Grant information</h2><p>This work was funded by NIH R01HL124477 to Nicola M. Heller for Mireya Becerra-Díaz and Nicola M. Heller and NIH RO1AI083315 and NIH U19AI070235 to Marsha Wills-Karp.</p><p><i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i>.</p></div><div class=back-section><a name=d7202e1609 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d8605>References</h2><div class="section ref-list"><a name=d7202e1609 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/10611956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1616 class=n-a></a>Lötvall J, Akdis CA, Bacharier LB, <i> et al.</i>: Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. <i>J Allergy Clin Immunol.</i> 2011; <b>127</b>(2): 355–60. <a target=xrefwindow id=d7202e1627 href="http://www.ncbi.nlm.nih.gov/pubmed/21281866">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1630 href="http://dx.doi.org/10.1016/j.jaci.2010.11.037">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/10611956">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1091113"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1643 class=n-a></a>Woodruff PG, Boushey HA, Dolganov GM, <i> et al.</i>: Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. <i>Proc Natl Acad Sci U S A.</i> 2007; <b>104</b>(40): 15858–63. <a target=xrefwindow id=d7202e1654 href="http://www.ncbi.nlm.nih.gov/pubmed/17898169">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1657 href="http://dx.doi.org/10.1073/pnas.0707413104">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1661 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2000427">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1091113">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1164541"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1674 class=n-a></a>Woodruff PG, Modrek B, Choy DF, <i> et al.</i>: T-helper type 2-driven inflammation defines major subphenotypes of asthma. <i>Am J Respir Crit Care Med.</i> 2009; <b>180</b>(5): 388–95. <a target=xrefwindow id=d7202e1685 href="http://www.ncbi.nlm.nih.gov/pubmed/19483109">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1688 href="http://dx.doi.org/10.1164/rccm.200903-0392OC">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1692 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2742757">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1164541">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718122966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1705 class=n-a></a>Peters MC, Mekonnen ZK, Yuan S, <i> et al.</i>: Measures of gene expression in sputum cells can identify T<sub>H</sub>2-high and T<sub>H</sub>2-low subtypes of asthma. <i>J Allergy Clin Immunol.</i> 2014; <b>133</b>(2): 388–94. <a target=xrefwindow id=d7202e1723 href="http://www.ncbi.nlm.nih.gov/pubmed/24075231">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1726 href="http://dx.doi.org/10.1016/j.jaci.2013.07.036">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1729 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3981552">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718122966">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718011925"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1743 class=n-a></a>Wenzel S, Ford L, Pearlman D, <i> et al.</i>: Dupilumab in persistent asthma with elevated eosinophil levels. <i>N Engl J Med.</i> 2013; <b>368</b>(26): 2455–66. <a target=xrefwindow id=d7202e1754 href="http://www.ncbi.nlm.nih.gov/pubmed/23688323">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1757 href="http://dx.doi.org/10.1056/NEJMoa1304048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718011925">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d7202e1771 class=n-a></a>Choy DF, Modrek B, Abbas AR, <i> et al.</i>: Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. <i>J Immunol.</i> 2011; <b>186</b>(3): 1861–9. <a target=xrefwindow id=d7202e1782 href="http://www.ncbi.nlm.nih.gov/pubmed/21187436">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1785 href="http://dx.doi.org/10.4049/jimmunol.1002568">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1789 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3981556">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/12609956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1798 class=n-a></a>Corren J, Lemanske RF, Hanania NA, <i> et al.</i>: Lebrikizumab treatment in adults with asthma. <i>N Engl J Med.</i> 2011; <b>365</b>(12): 1088–98. <a target=xrefwindow id=d7202e1809 href="http://www.ncbi.nlm.nih.gov/pubmed/21812663">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1812 href="http://dx.doi.org/10.1056/NEJMoa1106469">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/12609956">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d7202e1825 class=n-a></a>Bullens DM, Truyen E, Coteur L, <i> et al.</i>: IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? <i>Respir Res.</i> 2006; <b>7</b>: 135. <a target=xrefwindow id=d7202e1836 href="http://www.ncbi.nlm.nih.gov/pubmed/17083726">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1839 href="http://dx.doi.org/10.1186/1465-9921-7-135">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1843 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1636037">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d7202e1852 class=n-a></a>Lemière C, Ernst P, Olivenstein R, <i> et al.</i>: Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. <i>J Allergy Clin Immunol.</i> 2006; <b>118</b>(5): 1033–9. <a target=xrefwindow id=d7202e1863 href="http://www.ncbi.nlm.nih.gov/pubmed/17088126">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1866 href="http://dx.doi.org/10.1016/j.jaci.2006.08.003">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d7202e1875 class=n-a></a>Dardalhon V, Awasthi A, Kwon H, <i> et al.</i>: IL-4 inhibits TGF-beta-induced Foxp3<sup>+</sup> T cells and, together with TGF-beta, generates IL-9<sup>+</sup> IL-10<sup>+</sup> Foxp3<sup>-</sup> effector T cells. <i>Nat Immunol.</i> 2008; <b>9</b>(12): 1347–55. <a target=xrefwindow id=d7202e1899 href="http://www.ncbi.nlm.nih.gov/pubmed/18997793">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1902 href="http://dx.doi.org/10.1038/ni.1677">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1905 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2999006">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1125770"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1914 class=n-a></a>Veldhoen M, Uyttenhove C, van Snick J, <i> et al.</i>: Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. <i>Nat Immunol.</i> 2008; <b>9</b>(12): 1341–6. <a target=xrefwindow id=d7202e1925 href="http://www.ncbi.nlm.nih.gov/pubmed/18931678">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1928 href="http://dx.doi.org/10.1038/ni.1659">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1125770">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d7202e1942 class=n-a></a>Gour N, Wills-Karp M: IL-4 and IL-13 signaling in allergic airway disease. <i>Cytokine.</i> 2015; <b>75</b>(1): 68–78. <a target=xrefwindow id=d7202e1950 href="http://www.ncbi.nlm.nih.gov/pubmed/26070934">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1953 href="http://dx.doi.org/10.1016/j.cyto.2015.05.014">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1956 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4532591">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725568580"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e1965 class=n-a></a>Bao K, Reinhardt RL: The differential expression of IL-4 and IL-13 and its impact on type-2 immunity. <i>Cytokine.</i> 2015; <b>75</b>(1): 25–37. <a target=xrefwindow id=d7202e1973 href="http://www.ncbi.nlm.nih.gov/pubmed/26073683">PubMed Abstract </a> | <a target=xrefwindow id=d7202e1976 href="http://dx.doi.org/10.1016/j.cyto.2015.05.008">Publisher Full Text </a> | <a target=xrefwindow id=d7202e1979 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5118948">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725568580">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d7202e1992 class=n-a></a>Curran DR, Cohn L: Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease. <i>Am J Respir Cell Mol Biol.</i> 2010; <b>42</b>(3): 268–75. <a target=xrefwindow id=d7202e2000 href="http://www.ncbi.nlm.nih.gov/pubmed/19520914">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2003 href="http://dx.doi.org/10.1165/rcmb.2009-0151TR">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2006 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2830403">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725185250"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e2015 class=n-a></a>Laporte JC, Moore PE, Baraldo S, <i> et al.</i>: Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. <i>Am J Respir Crit Care Med.</i> 2001; <b>164</b>(1): 141–8. <a target=xrefwindow id=d7202e2026 href="http://www.ncbi.nlm.nih.gov/pubmed/11435252">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2029 href="http://dx.doi.org/10.1164/ajrccm.164.1.2008060">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725185250">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d7202e2042 class=n-a></a>Berair R, Hollins F, Brightling C: Airway smooth muscle hypercontractility in asthma. <i>J Allergy (Cairo).</i> 2013; <b>2013</b>: 185971. <a target=xrefwindow id=d7202e2050 href="http://www.ncbi.nlm.nih.gov/pubmed/23577039">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2053 href="http://dx.doi.org/10.1155/2013/185971">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2056 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3613096">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d7202e2065 class=n-a></a>Webb DC, Cai Y, Matthaei KI, <i> et al.</i>: Comparative roles of IL-4, IL-13, and IL-4Ralpha in dendritic cell maturation and CD4<sup>+</sup> Th2 cell function. <i>J Immunol.</i> 2007; <b>178</b>(1): 219–27. <a target=xrefwindow id=d7202e2079 href="http://www.ncbi.nlm.nih.gov/pubmed/17182558">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2083 href="http://dx.doi.org/10.4049/jimmunol.178.1.219">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d7202e2093 class=n-a></a>Ahn JS, Agrawal B: IL-4 is more effective than IL-13 for <i>in vitro</i> differentiation of dendritic cells from peripheral blood mononuclear cells. <i>Int Immunol.</i> 2005; <b>17</b>(10): 1337–46. <a target=xrefwindow id=d7202e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/16141241">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2107 href="http://dx.doi.org/10.1093/intimm/dxh312">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d7202e2116 class=n-a></a>Gaurav R, Agrawal DK: Clinical view on the importance of dendritic cells in asthma. <i>Expert Rev Clin Immunol.</i> 2013; <b>9</b>(10): 899–919. <a target=xrefwindow id=d7202e2124 href="http://www.ncbi.nlm.nih.gov/pubmed/24128155">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2127 href="http://dx.doi.org/10.1586/1744666X.2013.837260">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2130 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4479275">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718304528"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e2139 class=n-a></a>Halim TY, Steer CA, Mathä L, <i> et al.</i>: Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. <i>Immunity.</i> 2014; <b>40</b>(3): 425–35. <a target=xrefwindow id=d7202e2150 href="http://www.ncbi.nlm.nih.gov/pubmed/24613091">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2153 href="http://dx.doi.org/10.1016/j.immuni.2014.01.011">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2157 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4210641">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718304528">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d7202e2170 class=n-a></a>Roper RL, Conrad DH, Brown DM, <i> et al.</i>: Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis. <i>J Immunol.</i> 1990; <b>145</b>(8): 2644–51. <a target=xrefwindow id=d7202e2181 href="http://www.ncbi.nlm.nih.gov/pubmed/2170523">PubMed Abstract </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d7202e2190 class=n-a></a>Maggi E, Del Prete GF, Tiri A, <i> et al.</i>: Role of interleukin-4 in the induction of human IgE synthesis and its suppression by interferon-gamma. <i>Ric Clin Lab.</i> 1987; <b>17</b>(4): 363–7. <a target=xrefwindow id=d7202e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/3125596">PubMed Abstract </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d7202e2210 class=n-a></a>Graber P, Gretener D, Herren S, <i> et al.</i>: The distribution of IL-13 receptor alpha1 expression on B cells, T cells and monocytes and its regulation by IL-13 and IL-4. <i>Eur J Immunol.</i> 1998; <b>28</b>(12): 4286–98. <a target=xrefwindow id=d7202e2221 href="http://www.ncbi.nlm.nih.gov/pubmed/9862366">PubMed Abstract </a> | <a target="xrefwindow" id="d7202e2224" href="http://dx.doi.org/10.1002/(SICI)1521-4141(199812)28:12<4286::AID-IMMU4286&gt;3.0.CO;2-H">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d7202e2234 class=n-a></a>Doucet C, Brouty-Boyé D, Pottin-Clémenceau C, <i> et al.</i>: Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. <i>J Clin Invest.</i> 1998; <b>101</b>(10): 2129–39. <a target=xrefwindow id=d7202e2245 href="http://www.ncbi.nlm.nih.gov/pubmed/9593769">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2248 href="http://dx.doi.org/10.1172/JCI741">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2252 href="http://www.ncbi.nlm.nih.gov/pmc/articles/508801">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d7202e2261 class=n-a></a>Ishino T, Robertson N, Chaiken I: Cytokine recognition by human interleukin 5 receptor. <i>Vitam Horm.</i> 2005; <b>71</b>: 321–44. <a target=xrefwindow id=d7202e2269 href="http://www.ncbi.nlm.nih.gov/pubmed/16112273">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2272 href="http://dx.doi.org/10.1016/S0083-6729(05)71011-6">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d7202e2281 class=n-a></a>Flood-Page P, Swenson C, Faiferman I, <i> et al.</i>: A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. <i>Am J Respir Crit Care Med.</i> 2007; <b>176</b>(11): 1062–71. <a target=xrefwindow id=d7202e2292 href="http://www.ncbi.nlm.nih.gov/pubmed/17872493">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2295 href="http://dx.doi.org/10.1164/rccm.200701-085OC">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d7202e2304 class=n-a></a>Tabatabaian F, Ledford DK, Casale TB: Biologic and New Therapies in Asthma. <i>Immunol Allergy Clin North Am.</i> 2017; <b>37</b>(2): 329–43. <a target=xrefwindow id=d7202e2312 href="http://www.ncbi.nlm.nih.gov/pubmed/28366480">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2315 href="http://dx.doi.org/10.1016/j.iac.2017.01.007">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725376341"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e2324 class=n-a></a>Castro M, Zangrilli J, Wechsler ME: Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. <i>Lancet Respir Med.</i> 2015; <b>3</b>(5): 355–66. <a target=xrefwindow id=d7202e2332 href="http://www.ncbi.nlm.nih.gov/pubmed/25736990">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2335 href="http://dx.doi.org/10.1016/S2213-2600(15)00042-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725376341">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d7202e2348 class=n-a></a>Balhara J, Gounni AS: The alveolar macrophages in asthma: a double-edged sword. <i>Mucosal Immunol.</i> 2012; <b>5</b>(6): 605–9. <a target=xrefwindow id=d7202e2356 href="http://www.ncbi.nlm.nih.gov/pubmed/22910216">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2359 href="http://dx.doi.org/10.1038/mi.2012.74">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d7202e2369 class=n-a></a>Rőszer T: Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. <i>Mediators Inflamm.</i> 2015; <b>2015</b>: 816460. <a target=xrefwindow id=d7202e2377 href="http://www.ncbi.nlm.nih.gov/pubmed/26089604">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2380 href="http://dx.doi.org/10.1155/2015/816460">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2383 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4452191">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d7202e2392 class=n-a></a>Arango Duque G, Descoteaux A: Macrophage cytokines: involvement in immunity and infectious diseases. <i>Front Immunol.</i> 2014; <b>5</b>: 491. <a target=xrefwindow id=d7202e2400 href="http://www.ncbi.nlm.nih.gov/pubmed/25339958">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2403 href="http://dx.doi.org/10.3389/fimmu.2014.00491">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2406 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4188125">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726392763"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e2415 class=n-a></a>Girodet PO, Nguyen D, Mancini JD, <i> et al.</i>: Alternative Macrophage Activation Is Increased in Asthma. <i>Am J Respir Cell Mol Biol.</i> 2016; <b>55</b>(4): 467–75. <a target=xrefwindow id=d7202e2426 href="http://www.ncbi.nlm.nih.gov/pubmed/27248771">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2429 href="http://dx.doi.org/10.1165/rcmb.2015-0295OC">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2433 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5070104">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726392763">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d7202e2446 class=n-a></a>Staples KJ, Hinks TS, Ward JA, <i> et al.</i>: Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17. <i>J Allergy Clin Immunol.</i> 2012; <b>130</b>(6): 1404–12.e7. <a target=xrefwindow id=d7202e2457 href="http://www.ncbi.nlm.nih.gov/pubmed/22981793">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2460 href="http://dx.doi.org/10.1016/j.jaci.2012.07.023">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2464 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3805016">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d7202e2473 class=n-a></a>Kim YG, Udayanga KG, Totsuka N, <i> et al.</i>: Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE<sub>2</sub>. <i>Cell Host Microbe.</i> 2014; <b>15</b>(1): 95–102. <a target=xrefwindow id=d7202e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/24439901">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2491 href="http://dx.doi.org/10.1016/j.chom.2013.12.010">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3957200">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d7202e2503 class=n-a></a>Melgert BN, ten Hacken NH, Rutgers B, <i> et al.</i>: More alternative activation of macrophages in lungs of asthmatic patients. <i>J Allergy Clin Immunol.</i> 2011; <b>127</b>(3): 831–3. <a target=xrefwindow id=d7202e2514 href="http://www.ncbi.nlm.nih.gov/pubmed/21167569">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2517 href="http://dx.doi.org/10.1016/j.jaci.2010.10.045">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d7202e2527 class=n-a></a>Agapov E, Battaile JT, Tidwell R, <i> et al.</i>: Macrophage chitinase 1 stratifies chronic obstructive lung disease. <i>Am J Respir Cell Mol Biol.</i> 2009; <b>41</b>(4): 379–84. <a target=xrefwindow id=d7202e2538 href="http://www.ncbi.nlm.nih.gov/pubmed/19491341">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2541 href="http://dx.doi.org/10.1165/2009-0122R">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2545 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2746984">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d7202e2554 class=n-a></a>Winkler C, Witte L, Moraw N, <i> et al.</i>: Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics. <i>BMC Immunol.</i> 2014; <b>15</b>: 12. <a target=xrefwindow id=d7202e2565 href="http://www.ncbi.nlm.nih.gov/pubmed/24612750">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2568 href="http://dx.doi.org/10.1186/1471-2172-15-12">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2572 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4007705">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1113044"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e2581 class=n-a></a>Kim EY, Battaile JT, Patel AC, <i> et al.</i>: Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. <i>Nat Med.</i> 2008; <b>14</b>(6): 633–40. <a target=xrefwindow id=d7202e2592 href="http://www.ncbi.nlm.nih.gov/pubmed/18488036">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2595 href="http://dx.doi.org/10.1038/nm1770">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2599 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2575848">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1113044">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d7202e2612 class=n-a></a>Müller U, Stenzel W, Köhler G, <i> et al.</i>: IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with <i>Cryptococcus neoformans</i>. <i>J Immunol.</i> 2007; <b>179</b>(8): 5367–77. <a target=xrefwindow id=d7202e2626 href="http://www.ncbi.nlm.nih.gov/pubmed/17911623">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2630 href="http://dx.doi.org/10.4049/jimmunol.179.8.5367">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d7202e2639 class=n-a></a>Ford AQ, Dasgupta P, Mikhailenko I, <i> et al.</i>: Adoptive transfer of IL-4Rα<sup>+</sup> macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. <i>BMC Immunol.</i> 2012; <b>13</b>: 6. <a target=xrefwindow id=d7202e2653 href="http://www.ncbi.nlm.nih.gov/pubmed/22292924">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2657 href="http://dx.doi.org/10.1186/1471-2172-13-6">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2660 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3283450">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d7202e2669 class=n-a></a>Dasgupta P, Keegan AD: Contribution of alternatively activated macrophages to allergic lung inflammation: a tale of mice and men. <i>J Innate Immun.</i> 2012; <b>4</b>(5–6): 478–88. <a target=xrefwindow id=d7202e2677 href="http://www.ncbi.nlm.nih.gov/pubmed/22440980">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2680 href="http://dx.doi.org/10.1159/000336025">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d7202e2690 class=n-a></a>Draijer C, Robbe P, Boorsma CE, <i> et al.</i>: Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma. <i>Mediators Inflamm.</i> 2013; <b>2013</b>: 632049. <a target=xrefwindow id=d7202e2701 href="http://www.ncbi.nlm.nih.gov/pubmed/23533309">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2704 href="http://dx.doi.org/10.1155/2013/632049">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2708 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3600196">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d7202e2717 class=n-a></a>Lee CG, Hartl D, Lee GR, <i> et al.</i>: Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. <i>J Exp Med.</i> 2009; <b>206</b>(5): 1149–66. <a target=xrefwindow id=d7202e2728 href="http://www.ncbi.nlm.nih.gov/pubmed/19414556">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2731 href="http://dx.doi.org/10.1084/jem.20081271">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2735 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2715037">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/715898034"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e2744 class=n-a></a>Gibbons MA, MacKinnon AC, Ramachandran P, <i> et al.</i>: Ly6C<sup>hi</sup> monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. <i>Am J Respir Crit Care Med.</i> 2011; <b>184</b>(5): 569–81. <a target=xrefwindow id=d7202e2758 href="http://www.ncbi.nlm.nih.gov/pubmed/21680953">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2762 href="http://dx.doi.org/10.1164/rccm.201010-1719OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/715898034">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d7202e2775 class=n-a></a>Zhao A, Urban JF Jr, Anthony RM, <i> et al.</i>: Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. <i>Gastroenterology.</i> 2008; <b>135</b>(1): 217–225.e1. <a target=xrefwindow id=d7202e2786 href="http://www.ncbi.nlm.nih.gov/pubmed/18471439">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2789 href="http://dx.doi.org/10.1053/j.gastro.2008.03.077">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2793 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2954589">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d7202e2802 class=n-a></a>Migliaccio CT, Buford MC, Jessop F, <i> et al.</i>: The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis. <i>J Leukoc Biol.</i> 2008; <b>83</b>(3): 630–9. <a target=xrefwindow id=d7202e2813 href="http://www.ncbi.nlm.nih.gov/pubmed/18056481">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2816 href="http://dx.doi.org/10.1189/jlb.0807533">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d7202e2825 class=n-a></a>Zhen Y, Zheng J, Zhao Y: Regulatory CD4<sup>+</sup>CD25<sup>+</sup> T cells and macrophages: communication between two regulators of effector T cells. <i>Inflamm Res.</i> 2008; <b>57</b>(12): 564–70. <a target=xrefwindow id=d7202e2839 href="http://www.ncbi.nlm.nih.gov/pubmed/19109736">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2843 href="http://dx.doi.org/10.1007/s00011-008-7234-3">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d7202e2853 class=n-a></a>Hussell T, Bell TJ: Alveolar macrophages: plasticity in a tissue-specific context. <i>Nat Rev Immunol.</i> 2014; <b>14</b>(2): 81–93. <a target=xrefwindow id=d7202e2861 href="http://www.ncbi.nlm.nih.gov/pubmed/24445666">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2864 href="http://dx.doi.org/10.1038/nri3600">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d7202e2873 class=n-a></a>Lauzon-Joset JF, Marsolais D, Langlois A, <i> et al.</i>: Dysregulation of alveolar macrophages unleashes dendritic cell-mediated mechanisms of allergic airway inflammation. <i>Mucosal Immunol.</i> 2014; <b>7</b>(1): 155–64. <a target=xrefwindow id=d7202e2884 href="http://www.ncbi.nlm.nih.gov/pubmed/23715174">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2887 href="http://dx.doi.org/10.1038/mi.2013.34">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d7202e2896 class=n-a></a>McCormick SM, Heller NM: Commentary: IL-4 and IL-13 receptors and signaling. <i>Cytokine.</i> 2015; <b>75</b>(1): 38–50. <a target=xrefwindow id=d7202e2904 href="http://www.ncbi.nlm.nih.gov/pubmed/26187331">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2907 href="http://dx.doi.org/10.1016/j.cyto.2015.05.023">Publisher Full Text </a> | <a target=xrefwindow id=d7202e2910 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4546937">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d7202e2919 class=n-a></a>Heller NM, Dasgupta P, Dorsey NJ, <i> et al.</i>: The Type I and Type II Receptor Complexes for IL-4 and IL-13 Differentially Regulate Allergic Lung Inflammation, Allergic Diseases. In: Pereira C, editor. <i>Highlights in the Clinic, Mechanisms and Treatment</i>. 2012. <a target=xrefwindow id=d7202e2927 href="http://dx.doi.org/10.5772/25650">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d7202e2936 class=n-a></a>Barnes PJ: Pathophysiology of allergic inflammation. <i>Immunol Rev.</i> 2011; <b>242</b>(1): 31–50. <a target=xrefwindow id=d7202e2944 href="http://www.ncbi.nlm.nih.gov/pubmed/21682737">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2947 href="http://dx.doi.org/10.1111/j.1600-065X.2011.01020.x">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d7202e2956 class=n-a></a>Wills-Karp M, Luyimbazi J, Xu X, <i> et al.</i>: Interleukin-13: central mediator of allergic asthma. <i>Science.</i> 1998; <b>282</b>(5397): 2258–61. <a target=xrefwindow id=d7202e2967 href="http://www.ncbi.nlm.nih.gov/pubmed/9856949">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2970 href="http://dx.doi.org/10.1126/science.282.5397.2258">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d7202e2980 class=n-a></a>Barner M, Mohrs M, Brombacher F, <i> et al.</i>: Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. <i>Curr Biol.</i> 1998; <b>8</b>(11): 669–72. <a target=xrefwindow id=d7202e2991 href="http://www.ncbi.nlm.nih.gov/pubmed/9635196">PubMed Abstract </a> | <a target=xrefwindow id=d7202e2994 href="http://dx.doi.org/10.1016/S0960-9822(98)70256-8">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d7202e3003 class=n-a></a>Müller U, Piehler D, Stenzel W, <i> et al.</i>: Lack of IL-4 receptor expression on T helper cells reduces T helper 2 cell polyfunctionality and confers resistance in allergic bronchopulmonary mycosis. <i>Mucosal Immunol.</i> 2012; <b>5</b>(3): 299–310. <a target=xrefwindow id=d7202e3014 href="http://www.ncbi.nlm.nih.gov/pubmed/22333910">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3017 href="http://dx.doi.org/10.1038/mi.2012.9">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d7202e3026 class=n-a></a>Cortina SD, Drotar D, Ericksen M, <i> et al.</i>: Genetic biomarkers of health-related quality of life in pediatric asthma. <i>J Pediatr.</i> 2011; <b>159</b>(1): 21–26.e1. <a target=xrefwindow id=d7202e3037 href="http://www.ncbi.nlm.nih.gov/pubmed/21324477">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3040 href="http://dx.doi.org/10.1016/j.jpeds.2010.12.017">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3115404">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d7202e3053 class=n-a></a>Xue H, Sun K, Xie W, <i> et al.</i>: [Meta-analysis on interleukin-4 receptor α chain Q576R gene polymorphisms and bronchial asthma susceptibility]. <i>Zhonghua Jie He He Hu Xi Za Zhi.</i> 2010; <b>33</b>(11): 831–6. <a target=xrefwindow id=d7202e3064 href="http://www.ncbi.nlm.nih.gov/pubmed/21211370">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3067 href="http://dx.doi.org/10.3760/cma.j.issn.1001-0939.2010.11.006">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d7202e3076 class=n-a></a>Knutsen AP, Vijay HM, Kariuki B, <i> et al.</i>: Association of IL-4RA single nucleotide polymorphisms, HLA-DR and HLA-DQ in children with <i>Alternaria</i>-sensitive moderate-severe asthma. <i>Clin Mol Allergy.</i> 2010; <b>8</b>: 5. <a target=xrefwindow id=d7202e3090 href="http://www.ncbi.nlm.nih.gov/pubmed/20298583">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3094 href="http://dx.doi.org/10.1186/1476-7961-8-5">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3097 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2846861">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d7202e3106 class=n-a></a>McDonough H, Patterson C: CHIP: a link between the chaperone and proteasome systems. <i>Cell Stress Chaperones.</i> 2003; <b>8</b>(4): 303–8. <a target=xrefwindow id=d7202e3114 href="http://www.ncbi.nlm.nih.gov/pubmed/15115282">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3117 href="http://www.ncbi.nlm.nih.gov/pmc/articles/514901">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d7202e3127 class=n-a></a>Wei Q, Sha Y, Bhattacharya A, <i> et al.</i>: Regulation of IL-4 receptor signaling by STUB1 in lung inflammation. <i>Am J Respir Crit Care Med.</i> 2014; <b>189</b>(1): 16–29. <a target=xrefwindow id=d7202e3138 href="http://www.ncbi.nlm.nih.gov/pubmed/24251647">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3141 href="http://dx.doi.org/10.1164/rccm.201305-0874OC">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3145 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3919125">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1092477"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3154 class=n-a></a>Wenzel S, Wilbraham D, Fuller R, <i> et al.</i>: Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. <i>Lancet.</i> 2007; <b>370</b>(9596): 1422–31. <a target=xrefwindow id=d7202e3165 href="http://www.ncbi.nlm.nih.gov/pubmed/17950857">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3168 href="http://dx.doi.org/10.1016/S0140-6736(07)61600-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1092477">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d7202e3181 class=n-a></a>Wenzel SE, Ind PW, Otulana BA, <i> et al.</i>: Inhaled pitrakinra, an IL-4/IL-13 antagonist, reduced exacerbations in patients with eosinophilic asthma. <i>Eur Respir J.</i> 2010; <b>2010</b>; <b>36</b>: P3980: 1. <a target=xrefwindow id=d7202e3195 href="https://www.researchgate.net/publication/284260857_Inhaled_pitrakinra_an_IL-4IL-13_antagonist_reduced_exacerbations_in_patients_with_eosinophilic_asthma">Reference Source</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d7202e3204 class=n-a></a>Slager RE, Hawkins GA, Ampleford EJ, <i> et al.</i>: IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist. <i>J Allergy Clin Immunol.</i> 2010; <b>126</b>(4): 875–8. <a target=xrefwindow id=d7202e3215 href="http://www.ncbi.nlm.nih.gov/pubmed/20920778">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3218 href="http://dx.doi.org/10.1016/j.jaci.2010.08.001">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3222 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3772526">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1108687"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3231 class=n-a></a>Munitz A, Brandt EB, Mingler M, <i> et al.</i>: Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis. <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(20): 7240–5. <a target=xrefwindow id=d7202e3242 href="http://www.ncbi.nlm.nih.gov/pubmed/18480254">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3245 href="http://dx.doi.org/10.1073/pnas.0802465105">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3249 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2386078">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1108687">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d7202e3262 class=n-a></a>Wynn TA: IL-13 effector functions. <i>Annu Rev Immunol.</i> 2003; <b>21</b>: 425–56. <a target=xrefwindow id=d7202e3270 href="http://www.ncbi.nlm.nih.gov/pubmed/12615888">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3273 href="http://dx.doi.org/10.1146/annurev.immunol.21.120601.141142">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1097388"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3283 class=n-a></a>Ramalingam TR, Pesce JT, Sheikh F, <i> et al.</i>: Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. <i>Nat Immunol.</i> 2008; <b>9</b>(1): 25–33. <a target=xrefwindow id=d7202e3294 href="http://www.ncbi.nlm.nih.gov/pubmed/18066066">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3297 href="http://dx.doi.org/10.1038/ni1544">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3301 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2692551">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1097388">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725625029"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3314 class=n-a></a>Karo-Atar D, Bordowitz A, Wand O, <i> et al.</i>: A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair. <i>Mucosal Immunol.</i> 2016; <b>9</b>(1): 240–53. <a target=xrefwindow id=d7202e3325 href="http://www.ncbi.nlm.nih.gov/pubmed/26153764">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3328 href="http://dx.doi.org/10.1038/mi.2015.56">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3332 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4703942">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725625029">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725624070"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3345 class=n-a></a>Cao C, Zhao J, Doughty EK, <i> et al.</i>: Mac-1 Regulates IL-13 Activity in Macrophages by Directly Interacting with IL-13Rα1. <i>J Biol Chem.</i> 2015; <b>290</b>(35): 21642–51. <a target=xrefwindow id=d7202e3356 href="http://www.ncbi.nlm.nih.gov/pubmed/26160172">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3359 href="http://dx.doi.org/10.1074/jbc.M115.645796">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3363 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4571887">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725624070">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9893962"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3376 class=n-a></a>Gauvreau GM, Boulet L, Cockcroft DW, <i> et al.</i>: Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. <i>Am J Respir Crit Care Med.</i> 2011; <b>183</b>(8): 1007–14. <a target=xrefwindow id=d7202e3387 href="http://www.ncbi.nlm.nih.gov/pubmed/21057005">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3390 href="http://dx.doi.org/10.1164/rccm.201008-1210OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9893962">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d7202e3403 class=n-a></a>De Boever EH, Ashman C, Cahn AP, <i> et al.</i>: Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial. <i>J Allergy Clin Immunol.</i> 2014; <b>133</b>(4): 989–96. <a target=xrefwindow id=d7202e3414 href="http://www.ncbi.nlm.nih.gov/pubmed/24582316">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3417 href="http://dx.doi.org/10.1016/j.jaci.2014.01.002">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d7202e3426 class=n-a></a>Noonan M, Korenblat P, Mosesova S, <i> et al.</i>: Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids. <i>J Allergy Clin Immunol.</i> 2013; <b>132</b>(3): 567–574.e12. <a target=xrefwindow id=d7202e3437 href="http://www.ncbi.nlm.nih.gov/pubmed/23726041">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3440 href="http://dx.doi.org/10.1016/j.jaci.2013.03.051">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d7202e3450 class=n-a></a>Feng N, Lugli SM, Schnyder B, <i> et al.</i>: The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. <i>Lab Invest.</i> 1998; <b>78</b>(5): 591–602. <a target=xrefwindow id=d7202e3461 href="http://www.ncbi.nlm.nih.gov/pubmed/9605184">PubMed Abstract </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d7202e3470 class=n-a></a>Wang W, Shen YX, Li J, <i> et al.</i>: Enhanced expression of the decoy receptor IL-13Ralpha2 in macrophages of Schistosoma japonicum-infected mice. <i>Chin Med J (Engl).</i> 2009; <b>122</b>(14): 1650–4. <a target=xrefwindow id=d7202e3481 href="http://www.ncbi.nlm.nih.gov/pubmed/19719966">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3484 href="http://dx.doi.org/10.3760/cma.j.issn.0366-6999.2009.14.009">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726740013"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3493 class=n-a></a>Lee CM, He CH, Nour AM, <i> et al.</i>: IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses. <i>Nat Commun.</i> 2016; <b>7</b>: 12752. <a target=xrefwindow id=d7202e3504 href="http://www.ncbi.nlm.nih.gov/pubmed/27629921">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3507 href="http://dx.doi.org/10.1038/ncomms12752">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3511 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5027616">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726740013">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8011"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3524 class=n-a></a>Fichtner-Feigl S, Strober W, Kawakami K, <i> et al.</i>: IL-13 signaling through the IL-13alpha<sub>2</sub> receptor is involved in induction of TGF-beta<sub>1</sub> production and fibrosis. <i>Nat Med.</i> 2006; <b>12</b>(1): 99–106. <a target=xrefwindow id=d7202e3542 href="http://www.ncbi.nlm.nih.gov/pubmed/16327802">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3545 href="http://dx.doi.org/10.1038/nm1332">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8011">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d7202e3558 class=n-a></a>Mandal D, Levine AD: Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway. <i>Inflamm Bowel Dis.</i> 2010; <b>16</b>(5): 753–64. <a target=xrefwindow id=d7202e3566 href="http://www.ncbi.nlm.nih.gov/pubmed/20014020">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3569 href="http://dx.doi.org/10.1002/ibd.21133">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3572 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3417296">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d7202e3581 class=n-a></a>Chen W, Sivaprasad U, Gibson AM, <i> et al.</i>: IL-13 receptor α2 contributes to development of experimental allergic asthma. <i>J Allergy Clin Immunol.</i> 2013; <b>132</b>(4): 951–8.e1–6. <a target=xrefwindow id=d7202e3592 href="http://www.ncbi.nlm.nih.gov/pubmed/23763980">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3595 href="http://dx.doi.org/10.1016/j.jaci.2013.04.016">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3599 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3836839">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727701504"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3609 class=n-a></a>Nezgovorova V, Liu Q, Hu B, <i> et al.</i>: Sputum Gene Expression of IL-13 Receptor α2 Chain Correlates with Airflow Obstruction and Helper T-Cell Type 2 Inflammation in Asthma. <i>Ann Am Thorac Soc.</i> 2016; <b>13</b>(Suppl 1): S96–7. <a target=xrefwindow id=d7202e3620 href="http://www.ncbi.nlm.nih.gov/pubmed/27027964">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3623 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5015742">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727701504">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d7202e3636 class=n-a></a>Kuperman DA, Schleimer RP: Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma. <i>Curr Mol Med.</i> 2008; <b>8</b>(5): 384–92. <a target=xrefwindow id=d7202e3644 href="http://www.ncbi.nlm.nih.gov/pubmed/18691065">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3647 href="http://dx.doi.org/10.2174/156652408785161032">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3650 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4437630">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d7202e3659 class=n-a></a>Heller NM, Qi X, Junttila IS, <i> et al.</i>: Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. <i>Sci Signal.</i> 2008; <b>1</b>(51): ra17. <a target=xrefwindow id=d7202e3670 href="http://www.ncbi.nlm.nih.gov/pubmed/19109239">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3673 href="http://dx.doi.org/10.1126/scisignal.1164795">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3677 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2739727">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d7202e3686 class=n-a></a>Dasgupta P, Dorsey NJ, Li J, <i> et al.</i>: The adaptor protein insulin receptor substrate 2 inhibits alternative macrophage activation and allergic lung inflammation. <i>Sci Signal.</i> 2016; <b>9</b>(433): ra63. <a target=xrefwindow id=d7202e3697 href="http://www.ncbi.nlm.nih.gov/pubmed/27330190">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3700 href="http://dx.doi.org/10.1126/scisignal.aad6724">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d7202e3709 class=n-a></a>McCormick SM, Gowda N, Fang JX, <i> et al.</i>: Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome. <i>J Biol Chem.</i> 2016; <b>291</b>(39): 20574–87. <a target=xrefwindow id=d7202e3720 href="http://www.ncbi.nlm.nih.gov/pubmed/27507812">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3723 href="http://dx.doi.org/10.1074/jbc.M116.746164">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3727 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5034051">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d7202e3736 class=n-a></a>Meguro K, Nakagomi D, Suzuki K, <i> et al.</i>: SOCS3 Expressed in M2 Macrophages Attenuates Contact Hypersensitivity by Suppressing MMP-12 Production. <i>J Invest Dermatol.</i> 2016; <b>136</b>(3): 649–57. <a target=xrefwindow id=d7202e3747 href="http://www.ncbi.nlm.nih.gov/pubmed/27015453">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3750 href="http://dx.doi.org/10.1016/j.jid.2015.12.010">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d7202e3760 class=n-a></a>Kubo M, Inoue H: Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia. <i>Curr Allergy Asthma Rep.</i> 2006; <b>6</b>(1): 32–9. <a target=xrefwindow id=d7202e3768 href="http://www.ncbi.nlm.nih.gov/pubmed/16476192">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3771 href="http://dx.doi.org/10.1007/s11882-006-0007-6">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d7202e3780 class=n-a></a>López E, Zafra MP, Sastre B, <i> et al.</i>: Suppressors of cytokine signaling 3 expression in eosinophils: regulation by PGE<sub>2</sub> and Th2 cytokines. <i>Clin Dev Immunol.</i> 2011; <b>2011</b>: 917015. <a target=xrefwindow id=d7202e3794 href="http://www.ncbi.nlm.nih.gov/pubmed/21765854">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3798 href="http://dx.doi.org/10.1155/2011/917015">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3801 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3135166">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d7202e3810 class=n-a></a>Fukuyama S, Nakano T, Matsumoto T, <i> et al.</i>: Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype. <i>Am J Respir Crit Care Med.</i> 2009; <b>179</b>(11): 992–8. <a target=xrefwindow id=d7202e3821 href="http://www.ncbi.nlm.nih.gov/pubmed/19299500">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3824 href="http://dx.doi.org/10.1164/rccm.200806-992OC">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d7202e3833 class=n-a></a>Horiuchi Y, Bae SJ, Katayama I: Overexpression of the suppressor of cytokine signalling 3 (SOCS3) in severe atopic dermatitis. <i>Clin Exp Dermatol.</i> 2006; <b>31</b>(1): 100–4. <a target=xrefwindow id=d7202e3841 href="http://www.ncbi.nlm.nih.gov/pubmed/16309496">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3844 href="http://dx.doi.org/10.1111/j.1365-2230.2005.01979.x">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d7202e3853 class=n-a></a>Seki Y, Inoue H, Nagata N, <i> et al.</i>: SOCS-3 regulates onset and maintenance of T<sub>(H)</sub>2-mediated allergic responses. <i>Nat Med.</i> 2003; <b>9</b>(8): 1047–54. <a target=xrefwindow id=d7202e3867 href="http://www.ncbi.nlm.nih.gov/pubmed/12847520">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3871 href="http://dx.doi.org/10.1038/nm896">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d7202e3880 class=n-a></a>Mostecki J, Cassel SL, Klimecki WT, <i> et al.</i>: A SOCS-1 promoter variant is associated with total serum IgE levels. <i>J Immunol.</i> 2011; <b>187</b>(5): 2794–802. <a target=xrefwindow id=d7202e3891 href="http://www.ncbi.nlm.nih.gov/pubmed/21795592">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3894 href="http://dx.doi.org/10.4049/jimmunol.0902569">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3898 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3159751">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d7202e3908 class=n-a></a>Jager LD, Dabelic R, Waiboci LW, <i> et al.</i>: The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis. <i>J Neuroimmunol.</i> 2011; <b>232</b>(1–2): 108–18. <a target=xrefwindow id=d7202e3919 href="http://www.ncbi.nlm.nih.gov/pubmed/21131060">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3922 href="http://dx.doi.org/10.1016/j.jneuroim.2010.10.018">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3926 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3053067">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d7202e3935 class=n-a></a>Mack I, Hector A, Ballbach M, <i> et al.</i>: The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases. <i>Mol Cell Pediatr.</i> 2015; <b>2</b>(1): 3. <a target=xrefwindow id=d7202e3946 href="http://www.ncbi.nlm.nih.gov/pubmed/26542293">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3949 href="http://dx.doi.org/10.1186/s40348-015-0014-6">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3953 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4530573">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13491983"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e3962 class=n-a></a>van Dyken SJ, Garcia D, Porter P, <i> et al.</i>: Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration. <i>J Immunol.</i> 2011; <b>187</b>(5): 2261–7. <a target=xrefwindow id=d7202e3973 href="http://www.ncbi.nlm.nih.gov/pubmed/21824866">PubMed Abstract </a> | <a target=xrefwindow id=d7202e3976 href="http://dx.doi.org/10.4049/jimmunol.1100972">Publisher Full Text </a> | <a target=xrefwindow id=d7202e3980 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3159725">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13491983">F1000 Recommendation</a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d7202e3993 class=n-a></a>Yasuda K, Muto T, Kawagoe T, <i> et al.</i>: Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. <i>Proc Natl Acad Sci U S A.</i> 2012; <b>109</b>(9): 3451–6. <a target=xrefwindow id=d7202e4004 href="http://www.ncbi.nlm.nih.gov/pubmed/22331917">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4007 href="http://dx.doi.org/10.1073/pnas.1201042109">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4011 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3295287">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726578367"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4020 class=n-a></a>Khosravi AR, Erle DJ: Chitin-Induced Airway Epithelial Cell Innate Immune Responses Are Inhibited by Carvacrol/Thymol. <i>PLoS One.</i> 2016; <b>11</b>(7): e0159459. <a target=xrefwindow id=d7202e4028 href="http://www.ncbi.nlm.nih.gov/pubmed/27463381">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4031 href="http://dx.doi.org/10.1371/journal.pone.0159459">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4034 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4962986">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726578367">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1019620"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4047 class=n-a></a>Zhu Z, Zheng T, Homer RJ, <i> et al.</i>: Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. <i>Science.</i> 2004; <b>304</b>(5677): 1678–82. <a target=xrefwindow id=d7202e4058 href="http://www.ncbi.nlm.nih.gov/pubmed/15192232">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4061 href="http://dx.doi.org/10.1126/science.1095336">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1019620">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d7202e4075 class=n-a></a>Chupp GL, Lee CG, Jarjour N, <i> et al.</i>: A chitinase-like protein in the lung and circulation of patients with severe asthma. <i>N Engl J Med.</i> 2007; <b>357</b>(20): 2016–27. <a target=xrefwindow id=d7202e4086 href="http://www.ncbi.nlm.nih.gov/pubmed/18003958">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4089 href="http://dx.doi.org/10.1056/NEJMoa073600">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d7202e4098 class=n-a></a>Park JA, Drazen JM, Tschumperlin DJ: The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress. <i>J Biol Chem.</i> 2010; <b>285</b>(39): 29817–25. <a target=xrefwindow id=d7202e4106 href="http://www.ncbi.nlm.nih.gov/pubmed/20650887">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4109 href="http://dx.doi.org/10.1074/jbc.M110.103416">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4112 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2943267">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d7202e4121 class=n-a></a>Tang H, Shi Z, Xiu Q, <i> et al.</i>: YKL-40-mediated interleukin 8 production may be closely associated with remodeling of bronchial smooth muscle cells. <i>Am J Respir Crit Care Med.</i> 2012; <b>186</b>(4): 386; author reply 386–7. <a target=xrefwindow id=d7202e4132 href="http://www.ncbi.nlm.nih.gov/pubmed/22896594">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4135 href="http://dx.doi.org/10.1164/ajrccm.186.4.386a">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d7202e4144 class=n-a></a>Liu C, Li Q, Zhou X, <i> et al.</i>: The chitinase-like protein YKL-40 increases mucin5AC production in human bronchial epithelial cells. <i>Exp Cell Res.</i> 2013; <b>319</b>(18): 2866–73. <a target=xrefwindow id=d7202e4155 href="http://www.ncbi.nlm.nih.gov/pubmed/23994362">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4158 href="http://dx.doi.org/10.1016/j.yexcr.2013.08.009">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717697908"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4167 class=n-a></a>Bara I, Ozier A, Girodet PO, <i> et al.</i>: Role of YKL-40 in bronchial smooth muscle remodeling in asthma. <i>Am J Respir Crit Care Med.</i> 2012; <b>185</b>(7): 715–22. <a target=xrefwindow id=d7202e4178 href="http://www.ncbi.nlm.nih.gov/pubmed/22281830">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4181 href="http://dx.doi.org/10.1164/rccm.201105-0915OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717697908">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d7202e4194 class=n-a></a>Holcomb IN, Kabakoff RC, Chan B, <i> et al.</i>: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. <i>EMBO J.</i> 2000; <b>19</b>(15): 4046–55. <a target=xrefwindow id=d7202e4205 href="http://www.ncbi.nlm.nih.gov/pubmed/10921885">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4208 href="http://dx.doi.org/10.1093/emboj/19.15.4046">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4212 href="http://www.ncbi.nlm.nih.gov/pmc/articles/306596">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d7202e4222 class=n-a></a>Ma WL, Ye H, Tao XN, <i> et al.</i>: [Dynamic changes of found in inflammatory zone 1 protein and mRNA expression in the lung with experimental pulmonary fibrosis of the rat.]. <i>Sheng Li Xue Bao.</i> 2005; <b>57</b>(4): 493–7. <a target=xrefwindow id=d7202e4233 href="http://www.ncbi.nlm.nih.gov/pubmed/16094498">PubMed Abstract </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d7202e4242 class=n-a></a>Reece JJ, Siracusa MC, Scott AL: Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages. <i>Infect Immun.</i> 2006; <b>74</b>(9): 4970–81. <a target=xrefwindow id=d7202e4250 href="http://www.ncbi.nlm.nih.gov/pubmed/16926388">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4253 href="http://dx.doi.org/10.1128/IAI.00687-06">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4256 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1594865">Free Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d7202e4265 class=n-a></a>Lee MR, Shim D, Yoon J, <i> et al.</i>: Retnla overexpression attenuates allergic inflammation of the airway. <i>PLoS One.</i> 2014; <b>9</b>(11): e112666. <a target=xrefwindow id=d7202e4276 href="http://www.ncbi.nlm.nih.gov/pubmed/25415454">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4279 href="http://dx.doi.org/10.1371/journal.pone.0112666">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4283 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4240542">Free Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1159032"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4292 class=n-a></a>Nair MG, Du Y, Perrigoue JG, <i> et al.</i>: Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. <i>J Exp Med.</i> 2009; <b>206</b>(4): 937–52. <a target=xrefwindow id=d7202e4303 href="http://www.ncbi.nlm.nih.gov/pubmed/19349464">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4306 href="http://dx.doi.org/10.1084/jem.20082048">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4310 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2715126">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1159032">F1000 Recommendation</a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726258768"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4323 class=n-a></a>Chan PY, Carrera Silva EA, De Kouchkovsky D, <i> et al.</i>: The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity. <i>Science.</i> 2016; <b>352</b>(6281): 99–103. <a target=xrefwindow id=d7202e4334 href="http://www.ncbi.nlm.nih.gov/pubmed/27034374">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4337 href="http://dx.doi.org/10.1126/science.aaf1358">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4341 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4935984">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726258768">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718122935"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4354 class=n-a></a>Gao Y, Nish SA, Jiang R, <i> et al.</i>: Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. <i>Immunity.</i> 2013; <b>39</b>(4): 722–32. <a target=xrefwindow id=d7202e4365 href="http://www.ncbi.nlm.nih.gov/pubmed/24076050">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4368 href="http://dx.doi.org/10.1016/j.immuni.2013.08.028">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4372 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4110745">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718122935">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d7202e4386 class=n-a></a>Kumamoto Y, Linehan M, Weinstein JS, <i> et al.</i>: CD301b<sup>+</sup> dermal dendritic cells drive T helper 2 cell-mediated immunity. <i>Immunity.</i> 2013; <b>39</b>(4): 733–43. <a target=xrefwindow id=d7202e4400 href="http://www.ncbi.nlm.nih.gov/pubmed/24076051">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4404 href="http://dx.doi.org/10.1016/j.immuni.2013.08.029">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4407 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3819035">Free Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d7202e4416 class=n-a></a>Griesser H, Mak TW: The T-cell receptor--structure, function, and clinical application. <i>Hematol Pathol.</i> 1994; <b>8</b>(1–2): 1–23. <a target=xrefwindow id=d7202e4424 href="http://www.ncbi.nlm.nih.gov/pubmed/8034554">PubMed Abstract </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/6254956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4433 class=n-a></a>Yoshimura S, Gerondopoulos A, Linford A, <i> et al.</i>: Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. <i>J Cell Biol.</i> 2010; <b>191</b>(2): 367–81. <a target=xrefwindow id=d7202e4444 href="http://www.ncbi.nlm.nih.gov/pubmed/20937701">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4447 href="http://dx.doi.org/10.1083/jcb.201008051">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4451 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2958468">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/6254956">F1000 Recommendation</a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726079826"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4464 class=n-a></a>Yang C, Hojer CD, Zhou M, <i> et al.</i>: Regulation of T Cell Receptor Signaling by DENND1B in T<sub>H</sub>2 Cells and Allergic Disease. <i>Cell.</i> 2016; <b>164</b>(1–2): 141–55. <a target=xrefwindow id=d7202e4478 href="http://www.ncbi.nlm.nih.gov/pubmed/26774822">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4482 href="http://dx.doi.org/10.1016/j.cell.2015.11.052">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726079826">F1000 Recommendation</a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d7202e4495 class=n-a></a>Nurieva RI, Zheng S, Jin W, <i> et al.</i>: The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation. <i>Immunity.</i> 2010; <b>32</b>(5): 670–80. <a target=xrefwindow id=d7202e4506 href="http://www.ncbi.nlm.nih.gov/pubmed/20493730">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4509 href="http://dx.doi.org/10.1016/j.immuni.2010.05.002">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4513 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2915546 ">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d7202e4522 class=n-a></a>Sahoo A, Alekseev A, Obertas L, <i> et al.</i>: Grail controls Th2 cell development by targeting STAT6 for degradation. <i>Nat Commun.</i> 2014; <b>5</b>: 4732. <a target=xrefwindow id=d7202e4533 href="http://www.ncbi.nlm.nih.gov/pubmed/25145352">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4536 href="http://dx.doi.org/10.1038/ncomms5732">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4540 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5100808">Free Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d7202e4550 class=n-a></a>Qiao G, Ying H, Zhao Y, <i> et al.</i>: E3 ubiquitin ligase Cbl-b suppresses proallergic T cell development and allergic airway inflammation. <i>Cell Rep.</i> 2014; <b>6</b>(4): 709–23. <a target=xrefwindow id=d7202e4561 href="http://www.ncbi.nlm.nih.gov/pubmed/24508458">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4564 href="http://dx.doi.org/10.1016/j.celrep.2014.01.012">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4568 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3969736">Free Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5274956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4577 class=n-a></a>Lajoie S, Lewkowich IP, Suzuki Y, <i> et al.</i>: Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. <i>Nat Immunol.</i> 2010; <b>11</b>(10): 928–35. <a target=xrefwindow id=d7202e4588 href="http://www.ncbi.nlm.nih.gov/pubmed/20802484">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4591 href="http://dx.doi.org/10.1038/ni.1926">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4595 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2943538">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5274956">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d7202e4608 class=n-a></a>Wakashin H, Hirose K, Maezawa Y, <i> et al.</i>: IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. <i>Am J Respir Crit Care Med.</i> 2008; <b>178</b>(10): 1023–32. <a target=xrefwindow id=d7202e4619 href="http://www.ncbi.nlm.nih.gov/pubmed/18787221">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4622 href="http://dx.doi.org/10.1164/rccm.200801-086OC">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726572676"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4631 class=n-a></a>Hall SL, Baker T, Lajoie S, <i> et al.</i>: IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation. <i>J Allergy Clin Immunol.</i> 2017; <b>139</b>(2): 462–471.e14. <a target=xrefwindow id=d7202e4642 href="http://www.ncbi.nlm.nih.gov/pubmed/27417023">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4645 href="http://dx.doi.org/10.1016/j.jaci.2016.04.037">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4649 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5149451">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726572676">F1000 Recommendation</a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725730922"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4662 class=n-a></a>Choy DF, Hart KM, Borthwick LA, <i> et al.</i>: T<sub>H</sub>2 and T<sub>H</sub>17 inflammatory pathways are reciprocally regulated in asthma. <i>Sci Transl Med.</i> 2015; <b>7</b>(301): 301ra129. <a target=xrefwindow id=d7202e4680 href="http://www.ncbi.nlm.nih.gov/pubmed/26290411">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4683 href="http://dx.doi.org/10.1126/scitranslmed.aab3142">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725730922">F1000 Recommendation</a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718169730"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4696 class=n-a></a>Busse WW, Holgate S, Kerwin E, <i> et al.</i>: Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. <i>Am J Respir Crit Care Med.</i> 2013; <b>188</b>(11): 1294–302. <a target=xrefwindow id=d7202e4707 href="http://www.ncbi.nlm.nih.gov/pubmed/24200404">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4710 href="http://dx.doi.org/10.1164/rccm.201212-2318OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718169730">F1000 Recommendation</a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d7202e4724 class=n-a></a>Maier E, Werner D, Duschl A, <i> et al.</i>: Human Th2 but not Th9 cells release IL-31 in a STAT6/NF-κB-dependent way. <i>J Immunol.</i> 2014; <b>193</b>(2): 645–54. <a target=xrefwindow id=d7202e4735 href="http://www.ncbi.nlm.nih.gov/pubmed/24943220">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4738 href="http://dx.doi.org/10.4049/jimmunol.1301836">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4742 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4766737">Free Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d7202e4751 class=n-a></a>Edukulla R, Singh B, Jegga AG, <i> et al.</i>: Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression. <i>J Biol Chem.</i> 2015; <b>290</b>(21): 13510–20. <a target=xrefwindow id=d7202e4762 href="http://www.ncbi.nlm.nih.gov/pubmed/25847241">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4765 href="http://dx.doi.org/10.1074/jbc.M114.622126">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4505597">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d7202e4778 class=n-a></a>Lai T, Wu D, Li W, <i> et al.</i>: Interleukin-31 expression and relation to disease severity in human asthma. <i>Sci Rep.</i> 2016; <b>6</b>: 22835. <a target=xrefwindow id=d7202e4789 href="http://www.ncbi.nlm.nih.gov/pubmed/26956917">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4792 href="http://dx.doi.org/10.1038/srep22835">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4783779">Free Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d7202e4805 class=n-a></a>Yu J, Han WC, Yun K, <i> et al.</i>: Identifying Polymorphisms in <i>IL-31</i> and Their Association with Susceptibility to Asthma. <i>Korean J Pathol.</i> 2012; <b>46</b>(2): 162–8. <a target=xrefwindow id=d7202e4819 href="http://www.ncbi.nlm.nih.gov/pubmed/23109996">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4823 href="http://dx.doi.org/10.4132/KoreanJPathol.2012.46.2.162">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3479782">Free Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d7202e4835 class=n-a></a>Perrigoue JG, Zaph C, Guild K, <i> et al.</i>: IL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infection. <i>J Immunol.</i> 2009; <b>182</b>(10): 6088–94. <a target=xrefwindow id=d7202e4846 href="http://www.ncbi.nlm.nih.gov/pubmed/19414760">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4849 href="http://dx.doi.org/10.4049/jimmunol.0802459">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4853 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2828776">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d7202e4862 class=n-a></a>Zhou B, Comeau MR, De Smedt T, <i> et al.</i>: Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. <i>Nat Immunol.</i> 2005; <b>6</b>(10): 1047–53. <a target=xrefwindow id=d7202e4873 href="http://www.ncbi.nlm.nih.gov/pubmed/16142237">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4876 href="http://dx.doi.org/10.1038/ni1247">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717973758"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4886 class=n-a></a>Han H, Headley MB, Xu W, <i> et al.</i>: Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages. <i>J Immunol.</i> 2013; <b>190</b>(3): 904–12. <a target=xrefwindow id=d7202e4897 href="http://www.ncbi.nlm.nih.gov/pubmed/23275605">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4900 href="http://dx.doi.org/10.4049/jimmunol.1201808">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4904 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3549221">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717973758">F1000 Recommendation</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717970977"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4917 class=n-a></a>Al-Shami A, Spolski R, Kelly J, <i> et al.</i>: A role for TSLP in the development of inflammation in an asthma model. <i>J Exp Med.</i> 2005; <b>202</b>(6): 829–39. <a target=xrefwindow id=d7202e4928 href="http://www.ncbi.nlm.nih.gov/pubmed/16172260">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4931 href="http://dx.doi.org/10.1084/jem.20050199">Publisher Full Text </a> | <a target=xrefwindow id=d7202e4935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2212950">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717970977">F1000 Recommendation</a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d7202e4948 class=n-a></a>Cheng DT, Ma C, Niewoehner J, <i> et al.</i>: Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. <i>J Allergy Clin Immunol.</i> 2013; <b>132</b>(2): 455–62. <a target=xrefwindow id=d7202e4959 href="http://www.ncbi.nlm.nih.gov/pubmed/23810153">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4962 href="http://dx.doi.org/10.1016/j.jaci.2013.05.011">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726333580"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e4971 class=n-a></a>Vannella KM, Ramalingam TR, Borthwick LA, <i> et al.</i>: Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis. <i>Sci Transl Med.</i> 2016; <b>8</b>(337): 337ra65. <a target=xrefwindow id=d7202e4982 href="http://www.ncbi.nlm.nih.gov/pubmed/27147589">PubMed Abstract </a> | <a target=xrefwindow id=d7202e4985 href="http://dx.doi.org/10.1126/scitranslmed.aaf1938">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726333580">F1000 Recommendation</a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d7202e4998 class=n-a></a>Kido M, Tanaka J, Aoki N, <i> et al.</i>: <i>Helicobacter pylori</i> promotes the production of thymic stromal lymphopoietin by gastric epithelial cells and induces dendritic cell-mediated inflammatory Th2 responses. <i>Infect Immun.</i> 2010; <b>78</b>(1): 108–14. <a target=xrefwindow id=d7202e5012 href="http://www.ncbi.nlm.nih.gov/pubmed/19841072">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5016 href="http://dx.doi.org/10.1128/IAI.00762-09">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5019 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2798197">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d7202e5028 class=n-a></a>Kitajima M, Lee H, Nakayama T, <i> et al.</i>: TSLP enhances the function of helper type 2 cells. <i>Eur J Immunol.</i> 2011; <b>41</b>(7): 1862–71. <a target=xrefwindow id=d7202e5039 href="http://www.ncbi.nlm.nih.gov/pubmed/21484783">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5042 href="http://dx.doi.org/10.1002/eji.201041195">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5046 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3124605">Free Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d7202e5056 class=n-a></a>Li H, Chen ZG, Liu H, <i> et al.</i>: Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP. <i>Exp Lung Res.</i> 2016; <b>42</b>(6): 322–33. <a target=xrefwindow id=d7202e5067 href="http://www.ncbi.nlm.nih.gov/pubmed/27541375">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5070 href="http://dx.doi.org/10.1080/01902148.2016.1215571">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/12768956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5079 class=n-a></a>Reardon C, Lechmann M, Brüstle A, <i> et al.</i>: Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation. <i>Immunity.</i> 2011; <b>35</b>(2): 223–35. <a target=xrefwindow id=d7202e5090 href="http://www.ncbi.nlm.nih.gov/pubmed/21820333">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5093 href="http://dx.doi.org/10.1016/j.immuni.2011.05.015">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5097 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3169330">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/12768956">F1000 Recommendation</a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d7202e5110 class=n-a></a>Noble CL, Abbas AR, Lees CW, <i> et al.</i>: Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis. <i>Inflamm Bowel Dis.</i> 2010; <b>16</b>(10): 1717–28. <a target=xrefwindow id=d7202e5121 href="http://www.ncbi.nlm.nih.gov/pubmed/20848455">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5124 href="http://dx.doi.org/10.1002/ibd.21263">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d7202e5133 class=n-a></a>Eri RD, Adams RJ, Tran TV, <i> et al.</i>: An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity. <i>Mucosal Immunol.</i> 2011; <b>4</b>(3): 354–64. <a target=xrefwindow id=d7202e5144 href="http://www.ncbi.nlm.nih.gov/pubmed/21107311">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5147 href="http://dx.doi.org/10.1038/mi.2010.74">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5151 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3130192">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1070699"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5160 class=n-a></a>Zaph C, Troy AE, Taylor BC, <i> et al.</i>: Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. <i>Nature.</i> 2007; <b>446</b>(7135): 552–6. <a target=xrefwindow id=d7202e5171 href="http://www.ncbi.nlm.nih.gov/pubmed/17322906">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5174 href="http://dx.doi.org/10.1038/nature05590">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1070699">F1000 Recommendation</a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8849956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5187 class=n-a></a>Biton M, Levin A, Slyper M, <i> et al.</i>: Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. <i>Nat Immunol.</i> 2011; <b>12</b>(3): 239–46. <a target=xrefwindow id=d7202e5198 href="http://www.ncbi.nlm.nih.gov/pubmed/21278735">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5201 href="http://dx.doi.org/10.1038/ni.1994">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8849956">F1000 Recommendation</a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d7202e5215 class=n-a></a>Blázquez AB, Mayer L, Berin MC: Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. <i>Gastroenterology.</i> 2010; <b>139</b>(4): 1301–9. <a target=xrefwindow id=d7202e5223 href="http://www.ncbi.nlm.nih.gov/pubmed/20600023">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5226 href="http://dx.doi.org/10.1053/j.gastro.2010.06.055">Publisher Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d7202e5235 class=n-a></a>Taylor BC, Zaph C, Troy AE, <i> et al.</i>: TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. <i>J Exp Med.</i> 2009; <b>206</b>(3): 655–67. <a target=xrefwindow id=d7202e5246 href="http://www.ncbi.nlm.nih.gov/pubmed/19273626">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5249 href="http://dx.doi.org/10.1084/jem.20081499">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5253 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2699121">Free Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718408876"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5262 class=n-a></a>Gauvreau GM, O'Byrne PM, Boulet LP, <i> et al.</i>: Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. <i>N Engl J Med.</i> 2014; <b>370</b>(22): 2102–10. <a target=xrefwindow id=d7202e5273 href="http://www.ncbi.nlm.nih.gov/pubmed/24846652">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5276 href="http://dx.doi.org/10.1056/NEJMoa1402895">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718408876">F1000 Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1003822"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5289 class=n-a></a>Fort MM, Cheung J, Yen D, <i> et al.</i>: IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies <i>in vivo</i>. <i>Immunity.</i> 2001; <b>15</b>(6): 985–95. <a target=xrefwindow id=d7202e5303 href="http://www.ncbi.nlm.nih.gov/pubmed/11754819">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5307 href="http://dx.doi.org/10.1016/S1074-7613(01)00243-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1003822">F1000 Recommendation</a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d7202e5320 class=n-a></a>Valizadeh A, Khosravi A, Zadeh LJ, <i> et al.</i>: Role of IL-25 in Immunity. <i>J Clin Diagn Res.</i> 2015; <b>9</b>(4): OE01–4. <a target=xrefwindow id=d7202e5331 href="http://www.ncbi.nlm.nih.gov/pubmed/26023586">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5334 href="http://dx.doi.org/10.7860/JCDR/2015/12235.5814">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5338 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4437101">Free Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726019071"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5347 class=n-a></a>von Moltke J, Ji M, Liang HE, <i> et al.</i>: Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. <i>Nature.</i> 2016; <b>529</b>(7585): 221–5. <a target=xrefwindow id=d7202e5358 href="http://www.ncbi.nlm.nih.gov/pubmed/26675736">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5361 href="http://dx.doi.org/10.1038/nature16161">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5365 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4830391">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726019071">F1000 Recommendation</a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d7202e5379 class=n-a></a>Gerbe F, Legraverend C, Jay P: The intestinal epithelium tuft cells: specification and function. <i>Cell Mol Life Sci.</i> 2012; <b>69</b>(17): 2907–17. <a target=xrefwindow id=d7202e5387 href="http://www.ncbi.nlm.nih.gov/pubmed/22527717">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5390 href="http://dx.doi.org/10.1007/s00018-012-0984-7">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5393 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3417095">Free Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d7202e5402 class=n-a></a>Gronke K, Diefenbach A: Tuft cell-derived IL-25 activates and maintains ILC2. <i>Immunol Cell Biol.</i> 2016; <b>94</b>(3): 221–3. <a target=xrefwindow id=d7202e5410 href="http://www.ncbi.nlm.nih.gov/pubmed/26975341">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5413 href="http://dx.doi.org/10.1038/icb.2016.10">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725451547"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5422 class=n-a></a>Willis CR, Siegel L, Leith A, <i> et al.</i>: IL-17RA Signaling in Airway Inflammation and Bronchial Hyperreactivity in Allergic Asthma. <i>Am J Respir Cell Mol Biol.</i> 2015; <b>53</b>(6): 810–21. <a target=xrefwindow id=d7202e5433 href="http://www.ncbi.nlm.nih.gov/pubmed/25919006">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5436 href="http://dx.doi.org/10.1165/rcmb.2015-0038OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725451547">F1000 Recommendation</a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/719128739"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5449 class=n-a></a>Beale J, Jayaraman A, Jackson DJ, <i> et al.</i>: Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. <i>Sci Transl Med.</i> 2014; <b>6</b>(256): 256ra134. <a target=xrefwindow id=d7202e5460 href="http://www.ncbi.nlm.nih.gov/pubmed/25273095">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5463 href="http://dx.doi.org/10.1126/scitranslmed.3009124">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5467 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4246061">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/719128739">F1000 Recommendation</a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1029918"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5480 class=n-a></a>Schmitz J, Owyang A, Oldham E, <i> et al.</i>: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. <i>Immunity.</i> 2005; <b>23</b>(5): 479–90. <a target=xrefwindow id=d7202e5491 href="http://www.ncbi.nlm.nih.gov/pubmed/16286016">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5494 href="http://dx.doi.org/10.1016/j.immuni.2005.09.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1029918">F1000 Recommendation</a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/6546960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5507 class=n-a></a>Moffatt MF, Gut IG, Demenais F, <i> et al.</i>: A large-scale, consortium-based genomewide association study of asthma. <i>N Engl J Med.</i> 2010; <b>363</b>(13): 1211–21. <a target=xrefwindow id=d7202e5518 href="http://www.ncbi.nlm.nih.gov/pubmed/20860503">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5521 href="http://dx.doi.org/10.1056/NEJMoa0906312">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5525 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4260321">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/6546960">F1000 Recommendation</a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726559725"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5539 class=n-a></a>Gordon ED, Simpson LJ, Rios CL, <i> et al.</i>: Alternative splicing of interleukin-33 and type 2 inflammation in asthma. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(31): 8765–70. <a target=xrefwindow id=d7202e5550 href="http://www.ncbi.nlm.nih.gov/pubmed/27432971">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5553 href="http://dx.doi.org/10.1073/pnas.1601914113">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4978244">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726559725">F1000 Recommendation</a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a name=d7202e5570 class=n-a></a>Bartemes KR, Iijima K, Kobayashi T, <i> et al.</i>: IL-33-responsive lineage<sup>-</sup> CD25<sup>+</sup> CD44<sup>(hi)</sup> lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. <i>J Immunol.</i> 2012; <b>188</b>(3): 1503–13. <a target=xrefwindow id=d7202e5591 href="http://www.ncbi.nlm.nih.gov/pubmed/22198948">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5594 href="http://dx.doi.org/10.4049/jimmunol.1102832">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5597 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3262877">Free Full Text </a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d7202e5606 class=n-a></a>Humphreys NE, Xu D, Hepworth MR, <i> et al.</i>: IL-33, a potent inducer of adaptive immunity to intestinal nematodes. <i>J Immunol.</i> 2008; <b>180</b>(4): 2443–9. <a target=xrefwindow id=d7202e5617 href="http://www.ncbi.nlm.nih.gov/pubmed/18250453">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5620 href="http://dx.doi.org/10.4049/jimmunol.180.4.2443">Publisher Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727097371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5629 class=n-a></a>de Kleer IM, Kool M, de Bruijn MJ, <i> et al.</i>: Perinatal Activation of the Interleukin-33 Pathway Promotes Type 2 Immunity in the Developing Lung. <i>Immunity.</i> 2016; <b>45</b>(6): 1285–98. <a target=xrefwindow id=d7202e5640 href="http://www.ncbi.nlm.nih.gov/pubmed/27939673">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5643 href="http://dx.doi.org/10.1016/j.immuni.2016.10.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727097371">F1000 Recommendation</a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d7202e5656 class=n-a></a>Xu D, Chan WL, Leung BP, <i> et al.</i>: Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. <i>J Exp Med.</i> 1998; <b>187</b>(5): 787–94. <a target=xrefwindow id=d7202e5667 href="http://www.ncbi.nlm.nih.gov/pubmed/9480988">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5670 href="http://dx.doi.org/10.1084/jem.187.5.787">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5674 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2212173">Free Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d7202e5683 class=n-a></a>Cayrol C, Girard JP: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. <i>Proc Natl Acad Sci U S A.</i> 2009; <b>106</b>(22): 9021–6. <a target=xrefwindow id=d7202e5691 href="http://www.ncbi.nlm.nih.gov/pubmed/19439663">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5694 href="http://dx.doi.org/10.1073/pnas.0812690106">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5697 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2690027">Free Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a name=d7202e5707 class=n-a></a>Lefrançais E, Duval A, Mirey E, <i> et al.</i>: Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(43): 15502–7. <a target=xrefwindow id=d7202e5718 href="http://www.ncbi.nlm.nih.gov/pubmed/25313073">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5721 href="http://dx.doi.org/10.1073/pnas.1410700111">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5725 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4217470">Free Full Text </a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a name=d7202e5734 class=n-a></a>Polumuri SK, Jayakar GG, Shirey KA, <i> et al.</i>: Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. <i>J Immunol.</i> 2012; <b>189</b>(1): 50–60. <a target=xrefwindow id=d7202e5745 href="http://www.ncbi.nlm.nih.gov/pubmed/22634618">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5748 href="http://dx.doi.org/10.4049/jimmunol.1003554">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5752 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3437667">Free Full Text </a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726664444"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5761 class=n-a></a>Yamazumi Y, Sasaki O, Imamura M, <i> et al.</i>: The RNA Binding Protein Mex-3B Is Required for IL-33 Induction in the Development of Allergic Airway Inflammation. <i>Cell Rep.</i> 2016; <b>16</b>(9): 2456–71. <a target=xrefwindow id=d7202e5772 href="http://www.ncbi.nlm.nih.gov/pubmed/27545879">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5775 href="http://dx.doi.org/10.1016/j.celrep.2016.07.062">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726664444">F1000 Recommendation</a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a name=d7202e5788 class=n-a></a>Garlanda C, Dinarello CA, Mantovani A: The interleukin-1 family: back to the future. <i>Immunity.</i> 2013; <b>39</b>(6): 1003–18. <a target=xrefwindow id=d7202e5796 href="http://www.ncbi.nlm.nih.gov/pubmed/24332029">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5799 href="http://dx.doi.org/10.1016/j.immuni.2013.11.010">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5802 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3933951">Free Full Text </a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a name=d7202e5811 class=n-a></a>Cayrol C, Girard JP: IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. <i>Curr Opin Immunol.</i> 2014; <b>31</b>: 31–7. <a target=xrefwindow id=d7202e5819 href="http://www.ncbi.nlm.nih.gov/pubmed/25278425">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5822 href="http://dx.doi.org/10.1016/j.coi.2014.09.004">Publisher Full Text </a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a name=d7202e5831 class=n-a></a>Moussion C, Ortega N, Girard JP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells <i>in vivo</i>: a novel 'alarmin'? <i>PLoS One.</i> 2008; <b>3</b>(10): e3331. <a target=xrefwindow id=d7202e5842 href="http://www.ncbi.nlm.nih.gov/pubmed/18836528">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5845 href="http://dx.doi.org/10.1371/journal.pone.0003331">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5849 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2556082">Free Full Text </a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a name=d7202e5859 class=n-a></a>Pichery M, Mirey E, Mercier P, <i> et al.</i>: Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: <i>in situ</i> analysis using a novel <i>Il-33-LacZ</i> gene trap reporter strain. <i>J Immunol.</i> 2012; <b>188</b>(7): 3488–95. <a target=xrefwindow id=d7202e5877 href="http://www.ncbi.nlm.nih.gov/pubmed/22371395">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5880 href="http://dx.doi.org/10.4049/jimmunol.1101977">Publisher Full Text </a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725957281"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5889 class=n-a></a>Hristova M, Habibovic A, Veith C, <i> et al.</i>: Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses. <i>J Allergy Clin Immunol.</i> 2016; <b>137</b>(5): 1545–1556.e11. <a target=xrefwindow id=d7202e5900 href="http://www.ncbi.nlm.nih.gov/pubmed/26597162">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5903 href="http://dx.doi.org/10.1016/j.jaci.2015.10.003">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5907 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4860024">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725957281">F1000 Recommendation</a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9437957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e5920 class=n-a></a>Kouzaki H, Iijima K, Kobayashi T, <i> et al.</i>: The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. <i>J Immunol.</i> 2011; <b>186</b>(7): 4375–87. <a target=xrefwindow id=d7202e5931 href="http://www.ncbi.nlm.nih.gov/pubmed/21357533">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5934 href="http://dx.doi.org/10.4049/jimmunol.1003020">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5938 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3062674">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9437957">F1000 Recommendation</a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a name=d7202e5951 class=n-a></a>Kakkar R, Hei H, Dobner S, <i> et al.</i>: Interleukin 33 as a mechanically responsive cytokine secreted by living cells. <i>J Biol Chem.</i> 2012; <b>287</b>(9): 6941–8. <a target=xrefwindow id=d7202e5962 href="http://www.ncbi.nlm.nih.gov/pubmed/22215666">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5965 href="http://dx.doi.org/10.1074/jbc.M111.298703">Publisher Full Text </a> | <a target=xrefwindow id=d7202e5969 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3307313">Free Full Text </a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a name=d7202e5978 class=n-a></a>Tsuda H, Komine M, Karakawa M, <i> et al.</i>: Novel splice variants of IL-33: differential expression in normal and transformed cells. <i>J Invest Dermatol.</i> 2012; <b>132</b>(11): 2661–4. <a target=xrefwindow id=d7202e5989 href="http://www.ncbi.nlm.nih.gov/pubmed/22785132">PubMed Abstract </a> | <a target=xrefwindow id=d7202e5992 href="http://dx.doi.org/10.1038/jid.2012.180">Publisher Full Text </a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a name=d7202e6001 class=n-a></a>Ragusa R, Cabiati M, Guzzardi MA, <i> et al.</i>: Effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats. <i>Exp Mol Pathol.</i> 2017; <b>102</b>(2): 354–9. <a target=xrefwindow id=d7202e6012 href="http://www.ncbi.nlm.nih.gov/pubmed/28274612">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6015 href="http://dx.doi.org/10.1016/j.yexmp.2017.03.002">Publisher Full Text </a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a name=d7202e6025 class=n-a></a>Stav-Noraas TE, Edelmann RJ, La Poulsen LC, <i> et al.</i>: Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery. <i>J Immunol.</i> 2017; <b>198</b>(8): 3318–25. <a target=xrefwindow id=d7202e6036 href="http://www.ncbi.nlm.nih.gov/pubmed/28258201">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6039 href="http://dx.doi.org/10.4049/jimmunol.1600054">Publisher Full Text </a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727458980"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6048 class=n-a></a>Kouidhi S, Elgaaied AB, Chouaib S: Impact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment. <i>Front Immunol.</i> 2017; <b>8</b>: 270. <a target=xrefwindow id=d7202e6056 href="http://www.ncbi.nlm.nih.gov/pubmed/28348562">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6059 href="http://dx.doi.org/10.3389/fimmu.2017.00270">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6062 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5346542">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727458980">F1000 Recommendation</a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a name=d7202e6075 class=n-a></a>Laplante M, Sabatini DM: mTOR signaling in growth control and disease. <i>Cell.</i> 2012; <b>149</b>(2): 274–93. <a target=xrefwindow id=d7202e6083 href="http://www.ncbi.nlm.nih.gov/pubmed/22500797">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6086 href="http://dx.doi.org/10.1016/j.cell.2012.03.017">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6089 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3331679">Free Full Text </a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726230272"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6098 class=n-a></a>Chang CH, Pearce EL: Emerging concepts of T cell metabolism as a target of immunotherapy. <i>Nat Immunol.</i> 2016; <b>17</b>(4): 364–8. <a target=xrefwindow id=d7202e6106 href="http://www.ncbi.nlm.nih.gov/pubmed/27002844">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6109 href="http://dx.doi.org/10.1038/ni.3415">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6112 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4990080">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726230272">F1000 Recommendation</a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a name=d7202e6125 class=n-a></a>Rathmell JC: Metabolism and autophagy in the immune system: immunometabolism comes of age. <i>Immunol Rev.</i> 2012; <b>249</b>(1): 5–13. <a target=xrefwindow id=d7202e6133 href="http://www.ncbi.nlm.nih.gov/pubmed/22889211">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6136 href="http://dx.doi.org/10.1111/j.1600-065X.2012.01158.x">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6139 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3576876">Free Full Text </a></span></li><li><a name=ref-173 class=n-a></a><span class=label>173. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726375174"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6148 class=n-a></a>Xu W, Ghosh S, Comhair SA, <i> et al.</i>: Increased mitochondrial arginine metabolism supports bioenergetics in asthma. <i>J Clin Invest.</i> 2016; <b>126</b>(7): 2465–81. <a target=xrefwindow id=d7202e6159 href="http://www.ncbi.nlm.nih.gov/pubmed/27214549">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6162 href="http://dx.doi.org/10.1172/JCI82925">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6166 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4922712">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726375174">F1000 Recommendation</a></span></li><li><a name=ref-174 class=n-a></a><span class=label>174. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726263901"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6180 class=n-a></a>Monticelli LA, Buck MD, Flamar AL, <i> et al.</i>: Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. <i>Nat Immunol.</i> 2016; <b>17</b>(6): 656–65. <a target=xrefwindow id=d7202e6191 href="http://www.ncbi.nlm.nih.gov/pubmed/27043409">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6194 href="http://dx.doi.org/10.1038/ni.3421">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6198 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4873382">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726263901">F1000 Recommendation</a></span></li><li><a name=ref-175 class=n-a></a><span class=label>175. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718498323"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6211 class=n-a></a>Colegio OR, Chu NQ, Szabo AL, <i> et al.</i>: Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. <i>Nature.</i> 2014; <b>513</b>(7519): 559–63. <a target=xrefwindow id=d7202e6222 href="http://www.ncbi.nlm.nih.gov/pubmed/25043024">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6225 href="http://dx.doi.org/10.1038/nature13490">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6229 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4301845">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718498323">F1000 Recommendation</a></span></li><li><a name=ref-176 class=n-a></a><span class=label>176. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726282052"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6242 class=n-a></a>Selleri S, Bifsha P, Civini S, <i> et al.</i>: Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming. <i>Oncotarget.</i> 2016; <b>7</b>(21): 30193–210. <a target=xrefwindow id=d7202e6253 href="http://www.ncbi.nlm.nih.gov/pubmed/27070086">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6256 href="http://dx.doi.org/10.18632/oncotarget.8623">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6260 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5058674">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726282052">F1000 Recommendation</a></span></li><li><a name=ref-177 class=n-a></a><span class=label>177. </span>&nbsp;<span class=citation><a name=d7202e6273 class=n-a></a>Roncoroni AJ, Adrougué HJ, De Obrutsky CW, <i> et al.</i>: Metabolic acidosis in status asthmaticus. <i>Respiration.</i> 1976; <b>33</b>(2): 85–94. <a target=xrefwindow id=d7202e6284 href="http://www.ncbi.nlm.nih.gov/pubmed/778959">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6287 href="http://dx.doi.org/10.1159/000193721">Publisher Full Text </a></span></li><li><a name=ref-178 class=n-a></a><span class=label>178. </span>&nbsp;<span class=citation><a name=d7202e6296 class=n-a></a>Mountain RD, Heffner JE, Brackett NC Jr, <i> et al.</i>: Acid-base disturbances in acute asthma. <i>Chest.</i> 1990; <b>98</b>(3): 651–5. <a target=xrefwindow id=d7202e6307 href="http://www.ncbi.nlm.nih.gov/pubmed/2118447">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6310 href="http://dx.doi.org/10.1378/chest.98.3.651">Publisher Full Text </a></span></li><li><a name=ref-179 class=n-a></a><span class=label>179. </span>&nbsp;<span class=citation><a name=d7202e6319 class=n-a></a>Melgert BN, Oriss TB, Qi Z, <i> et al.</i>: Macrophages: regulators of sex differences in asthma? <i>Am J Respir Cell Mol Biol.</i> 2010; <b>42</b>(5): 595–603. <a target=xrefwindow id=d7202e6330 href="http://www.ncbi.nlm.nih.gov/pubmed/19574533">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6333 href="http://dx.doi.org/10.1165/rcmb.2009-0016OC">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6337 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2874445">Free Full Text </a></span></li><li><a name=ref-180 class=n-a></a><span class=label>180. </span>&nbsp;<span class=citation><a name=d7202e6347 class=n-a></a>Peter K, Rehli M, Singer K, <i> et al.</i>: Lactic acid delays the inflammatory response of human monocytes. <i>Biochem Biophys Res Commun.</i> 2015; <b>457</b>(3): 412–8. <a target=xrefwindow id=d7202e6358 href="http://www.ncbi.nlm.nih.gov/pubmed/25582773">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6361 href="http://dx.doi.org/10.1016/j.bbrc.2015.01.005">Publisher Full Text </a></span></li><li><a name=ref-181 class=n-a></a><span class=label>181. </span>&nbsp;<span class=citation><a name=d7202e6370 class=n-a></a>Dietl K, Renner K, Dettmer K, <i> et al.</i>: Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. <i>J Immunol.</i> 2010; <b>184</b>(3): 1200–9. <a target=xrefwindow id=d7202e6381 href="http://www.ncbi.nlm.nih.gov/pubmed/20026743">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6384 href="http://dx.doi.org/10.4049/jimmunol.0902584">Publisher Full Text </a></span></li><li><a name=ref-182 class=n-a></a><span class=label>182. </span>&nbsp;<span class=citation><a name=d7202e6393 class=n-a></a>Samuvel DJ, Sundararaj KP, Nareika A, <i> et al.</i>: Lactate boosts TLR4 signaling and NF-kappaB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. <i>J Immunol.</i> 2009; <b>182</b>(4): 2476–84. <a target=xrefwindow id=d7202e6404 href="http://www.ncbi.nlm.nih.gov/pubmed/19201903">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6407 href="http://dx.doi.org/10.4049/jimmunol.0802059">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2673542">Free Full Text </a></span></li><li><a name=ref-183 class=n-a></a><span class=label>183. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726673130"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6420 class=n-a></a>Abebayehu D, Spence AJ, Qayum AA, <i> et al.</i>: Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression. <i>J Immunol.</i> 2016; <b>197</b>(7): 2909–17. <a target=xrefwindow id=d7202e6431 href="http://www.ncbi.nlm.nih.gov/pubmed/27559047">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6434 href="http://dx.doi.org/10.4049/jimmunol.1600651">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6438 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5026940">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726673130">F1000 Recommendation</a></span></li><li><a name=ref-184 class=n-a></a><span class=label>184. </span>&nbsp;<span class=citation><a name=d7202e6451 class=n-a></a>Ananieva EA, Powell JD, Hutson SM: Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond. <i>Adv Nutr.</i> 2016; <b>7</b>(4): 798S–805S. <a target=xrefwindow id=d7202e6459 href="http://www.ncbi.nlm.nih.gov/pubmed/27422517">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6462 href="http://dx.doi.org/10.3945/an.115.011221">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6465 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4942864">Free Full Text </a></span></li><li><a name=ref-185 class=n-a></a><span class=label>185. </span>&nbsp;<span class=citation><a name=d7202e6474 class=n-a></a>Chi H: Regulation and function of mTOR signalling in T cell fate decisions. <i>Nat Rev Immunol.</i> 2012; <b>12</b>(5): 325–38. <a target=xrefwindow id=d7202e6482 href="http://www.ncbi.nlm.nih.gov/pubmed/22517423">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6485 href="http://dx.doi.org/10.1038/nri3198">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6488 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3417069">Free Full Text </a></span></li><li><a name=ref-186 class=n-a></a><span class=label>186. </span>&nbsp;<span class=citation><a name=d7202e6498 class=n-a></a>Weichhart T, Hengstschläger M, Linke M: Regulation of innate immune cell function by mTOR. <i>Nat Rev Immunol.</i> 2015; <b>15</b>(10): 599–614. <a target=xrefwindow id=d7202e6506 href="http://www.ncbi.nlm.nih.gov/pubmed/26403194">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6509 href="http://dx.doi.org/10.1038/nri3901">Publisher Full Text </a></span></li><li><a name=ref-187 class=n-a></a><span class=label>187. </span>&nbsp;<span class=citation><a name=d7202e6518 class=n-a></a>Sasaki CY, Chen G, Munk R, <i> et al.</i>: p(<sup>70</sup>S<sup>6</sup>K<sup>1</sup>) in the TORC1 pathway is essential for the differentiation of Th17 Cells, but not Th1, Th2, or Treg cells in mice. <i>Eur J Immunol.</i> 2016; <b>46</b>(1): 212–22. <a target=xrefwindow id=d7202e6539 href="http://www.ncbi.nlm.nih.gov/pubmed/26514620">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6542 href="http://dx.doi.org/10.1002/eji.201445422">Publisher Full Text </a></span></li><li><a name=ref-188 class=n-a></a><span class=label>188. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726857012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6551 class=n-a></a>Huang SC, Smith AM, Everts B, <i> et al.</i>: Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation. <i>Immunity.</i> 2016; <b>45</b>(4): 817–30. <a target=xrefwindow id=d7202e6562 href="http://www.ncbi.nlm.nih.gov/pubmed/27760338">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6565 href="http://dx.doi.org/10.1016/j.immuni.2016.09.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726857012">F1000 Recommendation</a></span></li><li><a name=ref-189 class=n-a></a><span class=label>189. </span>&nbsp;<span class=citation><a name=d7202e6578 class=n-a></a>Byles V, Covarrubias AJ, Ben-Sahra I, <i> et al.</i>: The TSC-mTOR pathway regulates macrophage polarization. <i>Nat Commun.</i> 2013; <b>4</b>: 2834. <a target=xrefwindow id=d7202e6589 href="http://www.ncbi.nlm.nih.gov/pubmed/24280772">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6592 href="http://dx.doi.org/10.1038/ncomms3834">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6596 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3876736">Free Full Text </a></span></li><li><a name=ref-190 class=n-a></a><span class=label>190. </span>&nbsp;<span class=citation><a name=d7202e6605 class=n-a></a>Zhu L, Yang T, Li L, <i> et al.</i>: TSC1 controls macrophage polarization to prevent inflammatory disease. <i>Nat Commun.</i> 2014; <b>5</b>: 4696. <a target=xrefwindow id=d7202e6616 href="http://www.ncbi.nlm.nih.gov/pubmed/25175012">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6619 href="http://dx.doi.org/10.1038/ncomms5696">Publisher Full Text </a></span></li><li><a name=ref-191 class=n-a></a><span class=label>191. </span>&nbsp;<span class=citation><a name=d7202e6628 class=n-a></a>Warren KJ, Fang X, Gowda NM, <i> et al.</i>: The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2. <i>J Biol Chem.</i> 2016; <b>291</b>(48): 24922–30. <a target=xrefwindow id=d7202e6639 href="http://www.ncbi.nlm.nih.gov/pubmed/27742835">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6642 href="http://dx.doi.org/10.1074/jbc.M116.756791">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6646 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5122764">Free Full Text </a></span></li><li><a name=ref-192 class=n-a></a><span class=label>192. </span>&nbsp;<span class=citation><a name=d7202e6656 class=n-a></a>Festuccia WT, Pouliot P, Bakan I, <i> et al.</i>: Myeloid-specific <i>Rictor</i> deletion induces M1 macrophage polarization and potentiates <i>in vivo</i> pro-inflammatory response to lipopolysaccharide. <i>PLoS One.</i> 2014; <b>9</b>(4): e95432. <a target=xrefwindow id=d7202e6674 href="http://www.ncbi.nlm.nih.gov/pubmed/24740015">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6677 href="http://dx.doi.org/10.1371/journal.pone.0095432">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3989321">Free Full Text </a></span></li><li><a name=ref-193 class=n-a></a><span class=label>193. </span>&nbsp;<span class=citation><a name=d7202e6689 class=n-a></a>Lee J, Kim TH, Murray F, <i> et al.</i>: Cyclic AMP concentrations in dendritic cells induce and regulate Th2 immunity and allergic asthma. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(5): 1529–34. <a target=xrefwindow id=d7202e6700 href="http://www.ncbi.nlm.nih.gov/pubmed/25605931">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6703 href="http://dx.doi.org/10.1073/pnas.1417972112">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6707 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4321256">Free Full Text </a></span></li><li><a name=ref-194 class=n-a></a><span class=label>194. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725634243"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6716 class=n-a></a>Al-Sawalha N, Pokkunuri I, Omoluabi O, <i> et al.</i>: Epinephrine Activation of the β<sub>2</sub>-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells. <i>PLoS One.</i> 2015; <b>10</b>(7): e0132559. <a target=xrefwindow id=d7202e6730 href="http://www.ncbi.nlm.nih.gov/pubmed/26161982">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6734 href="http://dx.doi.org/10.1371/journal.pone.0132559">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6737 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4498766">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725634243">F1000 Recommendation</a></span></li><li><a name=ref-195 class=n-a></a><span class=label>195. </span>&nbsp;<span class=citation><a name=d7202e6750 class=n-a></a>Roy SG, Nozaki Y, Phan SH: Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. <i>Int J Biochem Cell Biol.</i> 2001; <b>33</b>(7): 723–34. <a target=xrefwindow id=d7202e6758 href="http://www.ncbi.nlm.nih.gov/pubmed/11390280">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6761 href="http://dx.doi.org/10.1016/S1357-2725(01)00041-3">Publisher Full Text </a></span></li><li><a name=ref-196 class=n-a></a><span class=label>196. </span>&nbsp;<span class=citation><a name=d7202e6770 class=n-a></a>Kesavan R, Potunuru UR, Nastasijević B, <i> et al.</i>: Inhibition of vascular smooth muscle cell proliferation by <i>Gentiana lutea</i> root extracts. <i>PLoS One.</i> 2013; <b>8</b>(4): e61393. <a target=xrefwindow id=d7202e6784 href="http://www.ncbi.nlm.nih.gov/pubmed/23637826">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6788 href="http://dx.doi.org/10.1371/journal.pone.0061393">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6791 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3630200">Free Full Text </a></span></li><li><a name=ref-197 class=n-a></a><span class=label>197. </span>&nbsp;<span class=citation><a name=d7202e6800 class=n-a></a>Chen H, Xia Q, Feng X, <i> et al.</i>: Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice. <i>Mol Med Rep.</i> 2016; <b>13</b>(1): 697–704. <a target=xrefwindow id=d7202e6811 href="http://www.ncbi.nlm.nih.gov/pubmed/26648454">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6814 href="http://dx.doi.org/10.3892/mmr.2015.4622">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6818 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4686060">Free Full Text </a></span></li><li><a name=ref-198 class=n-a></a><span class=label>198. </span>&nbsp;<span class=citation><a name=d7202e6828 class=n-a></a>Kero J, Gissler M, Grönlund MM, <i> et al.</i>: Mode of delivery and asthma -- is there a connection? <i>Pediatr Res.</i> 2002; <b>52</b>(1): 6–11. <a target=xrefwindow id=d7202e6839 href="http://www.ncbi.nlm.nih.gov/pubmed/12084840">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6842 href="http://dx.doi.org/10.1203/00006450-200207000-00004">Publisher Full Text </a></span></li><li><a name=ref-199 class=n-a></a><span class=label>199. </span>&nbsp;<span class=citation><a name=d7202e6851 class=n-a></a>Bener A, Ehlayel MS, Alsowaidi S, <i> et al.</i>: Role of breast feeding in primary prevention of asthma and allergic diseases in a traditional society. <i>Eur Ann Allergy Clin Immunol.</i> 2007; <b>39</b>(10): 337–43. <a target=xrefwindow id=d7202e6862 href="http://www.ncbi.nlm.nih.gov/pubmed/18386435">PubMed Abstract </a></span></li><li><a name=ref-200 class=n-a></a><span class=label>200. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727109347"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6871 class=n-a></a>Gupta RS, Singh AM, Walkner M, <i> et al.</i>: Hygiene factors associated with childhood food allergy and asthma. <i>Allergy Asthma Proc.</i> 2016; <b>37</b>(6): 140–6. <a target=xrefwindow id=d7202e6882 href="http://www.ncbi.nlm.nih.gov/pubmed/27931290">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6885 href="http://dx.doi.org/10.2500/aap.2016.37.3988">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727109347">F1000 Recommendation</a></span></li><li><a name=ref-201 class=n-a></a><span class=label>201. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726746957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6898 class=n-a></a>Hasegawa K, Linnemann RW, Mansbach JM, <i> et al.</i>: Household siblings and nasal and fecal microbiota in infants. <i>Pediatr Int.</i> 2017; <b>59</b>(4): 473–81. <a target=xrefwindow id=d7202e6909 href="http://www.ncbi.nlm.nih.gov/pubmed/27638139">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6912 href="http://dx.doi.org/10.1111/ped.13168">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5354996">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726746957">F1000 Recommendation</a></span></li><li><a name=ref-202 class=n-a></a><span class=label>202. </span>&nbsp;<span class=citation><a name=d7202e6929 class=n-a></a>Douwes J, Cheng S, Travier N, <i> et al.</i>: Farm exposure <i>in utero</i> may protect against asthma, hay fever and eczema. <i>Eur Respir J.</i> 2008; <b>32</b>(3): 603–11. <a target=xrefwindow id=d7202e6943 href="http://www.ncbi.nlm.nih.gov/pubmed/18448493">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6947 href="http://dx.doi.org/10.1183/09031936.00033707">Publisher Full Text </a></span></li><li><a name=ref-203 class=n-a></a><span class=label>203. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718008689"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e6956 class=n-a></a>Russell SL, Gold MJ, Willing BP, <i> et al.</i>: Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. <i>Gut Microbes.</i> 2013; <b>4</b>(2): 158–64. <a target=xrefwindow id=d7202e6967 href="http://www.ncbi.nlm.nih.gov/pubmed/23333861">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6970 href="http://dx.doi.org/10.4161/gmic.23567">Publisher Full Text </a> | <a target=xrefwindow id=d7202e6974 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3595077">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718008689">F1000 Recommendation</a></span></li><li><a name=ref-204 class=n-a></a><span class=label>204. </span>&nbsp;<span class=citation><a name=d7202e6988 class=n-a></a>Murk W, Risnes KR, Bracken MB: Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review. <i>Pediatrics.</i> 2011; <b>127</b>(6): 1125–38. <a target=xrefwindow id=d7202e6996 href="http://www.ncbi.nlm.nih.gov/pubmed/21606151">PubMed Abstract </a> | <a target=xrefwindow id=d7202e6999 href="http://dx.doi.org/10.1542/peds.2010-2092">Publisher Full Text </a></span></li><li><a name=ref-205 class=n-a></a><span class=label>205. </span>&nbsp;<span class=citation><a name=d7202e7008 class=n-a></a>Lodge CJ, Dharmage SC: Breastfeeding and perinatal exposure, and the risk of asthma and allergies. <i>Curr Opin Allergy Clin Immunol.</i> 2016; <b>16</b>(3): 231–6. <a target=xrefwindow id=d7202e7016 href="http://www.ncbi.nlm.nih.gov/pubmed/27054317">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7019 href="http://dx.doi.org/10.1097/ACI.0000000000000266">Publisher Full Text </a></span></li><li><a name=ref-206 class=n-a></a><span class=label>206. </span>&nbsp;<span class=citation><a name=d7202e7028 class=n-a></a>Milner JD, Gergen PJ: Transient environmental exposures on the developing immune system: implications for allergy and asthma. <i>Curr Opin Allergy Clin Immunol.</i> 2005; <b>5</b>(3): 235–40. <a target=xrefwindow id=d7202e7036 href="http://www.ncbi.nlm.nih.gov/pubmed/15864081">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7039 href="http://dx.doi.org/10.1097/01.all.0000168787.59335.8a">Publisher Full Text </a></span></li><li><a name=ref-207 class=n-a></a><span class=label>207. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2115960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7048 class=n-a></a>Hilty M, Burke C, Pedro H, <i> et al.</i>: Disordered microbial communities in asthmatic airways. <i>PLoS One.</i> 2010; <b>5</b>(1): e8578. <a target=xrefwindow id=d7202e7059 href="http://www.ncbi.nlm.nih.gov/pubmed/20052417">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7062 href="http://dx.doi.org/10.1371/journal.pone.0008578">Publisher Full Text </a> | <a target=xrefwindow id=d7202e7066 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2798952">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2115960">F1000 Recommendation</a></span></li><li><a name=ref-208 class=n-a></a><span class=label>208. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8622960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7079 class=n-a></a>Huang YJ, Nelson CE, Brodie EL, <i> et al.</i>: Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. <i>J Allergy Clin Immunol.</i> 2011; <b>127</b>(2): 372–381.e1-3. <a target=xrefwindow id=d7202e7090 href="http://www.ncbi.nlm.nih.gov/pubmed/21194740">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7093 href="http://dx.doi.org/10.1016/j.jaci.2010.10.048">Publisher Full Text </a> | <a target=xrefwindow id=d7202e7097 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3037020">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8622960">F1000 Recommendation</a></span></li><li><a name=ref-209 class=n-a></a><span class=label>209. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725823144"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7110 class=n-a></a>Arrieta MC, Stiemsma LT, Dimitriu PA, <i> et al.</i>: Early infancy microbial and metabolic alterations affect risk of childhood asthma. <i>Sci Transl Med.</i> 2015; <b>7</b>(307): 307ra152. <a target=xrefwindow id=d7202e7121 href="http://www.ncbi.nlm.nih.gov/pubmed/26424567">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7124 href="http://dx.doi.org/10.1126/scitranslmed.aab2271">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725823144">F1000 Recommendation</a></span></li><li><a name=ref-210 class=n-a></a><span class=label>210. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/12279956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7138 class=n-a></a>Arnold IC, Dehzad N, Reuter S, <i> et al.</i>: <i>Helicobacter pylori</i> infection prevents allergic asthma in mouse models through the induction of regulatory T cells. <i>J Clin Invest.</i> 2011; <b>121</b>(8): 3088–93. <a target=xrefwindow id=d7202e7152 href="http://www.ncbi.nlm.nih.gov/pubmed/21737881">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7156 href="http://dx.doi.org/10.1172/JCI45041">Publisher Full Text </a> | <a target=xrefwindow id=d7202e7159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3148731">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/12279956">F1000 Recommendation</a></span></li><li><a name=ref-211 class=n-a></a><span class=label>211. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718178661"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7172 class=n-a></a>Cahenzli J, Köller Y, Wyss M, <i> et al.</i>: Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. <i>Cell Host Microbe.</i> 2013; <b>14</b>(5): 559–70. <a target=xrefwindow id=d7202e7183 href="http://www.ncbi.nlm.nih.gov/pubmed/24237701">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7186 href="http://dx.doi.org/10.1016/j.chom.2013.10.004">Publisher Full Text </a> | <a target=xrefwindow id=d7202e7190 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4049278">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718178661">F1000 Recommendation</a></span></li><li><a name=ref-212 class=n-a></a><span class=label>212. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718228193"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7203 class=n-a></a>Trompette A, Gollwitzer ES, Yadava K, <i> et al.</i>: Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. <i>Nat Med.</i> 2014; <b>20</b>(2): 159–66. <a target=xrefwindow id=d7202e7214 href="http://www.ncbi.nlm.nih.gov/pubmed/24390308">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7217 href="http://dx.doi.org/10.1038/nm.3444">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718228193">F1000 Recommendation</a></span></li><li><a name=ref-213 class=n-a></a><span class=label>213. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725300895"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7230 class=n-a></a>Kim CH, Park J, Kim M: Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. <i>Immune Netw.</i> 2014; <b>14</b>(6): 277–88. <a target=xrefwindow id=d7202e7238 href="http://www.ncbi.nlm.nih.gov/pubmed/25550694">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7241 href="http://dx.doi.org/10.4110/in.2014.14.6.277">Publisher Full Text </a> | <a target=xrefwindow id=d7202e7244 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4275385">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725300895">F1000 Recommendation</a></span></li><li><a name=ref-214 class=n-a></a><span class=label>214. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726490081"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d7202e7257 class=n-a></a>Tamburini S, Shen N, Wu HC, <i> et al.</i>: The microbiome in early life: implications for health outcomes. <i>Nat Med.</i> 2016; <b>22</b>(7): 713–22. <a target=xrefwindow id=d7202e7268 href="http://www.ncbi.nlm.nih.gov/pubmed/27387886">PubMed Abstract </a> | <a target=xrefwindow id=d7202e7271 href="http://dx.doi.org/10.1038/nm.4142">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726490081">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1014&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1014&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA<br/> <sup>2</sup> Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1014/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 28 Jun 2017, 6:1014 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11198.1">https://doi.org/10.12688/f1000research.11198.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Becerra-Díaz M <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12082 data-id=11198 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11198.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1014/v1/pdf?article_uuid=eacdf954-427a-4c4a-adc2-6818e2c5df34" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11198.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Becerra-Díaz M, Wills-Karp M and Heller NM. New perspectives on the regulation of type II inflammation in asthma [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1014 (<a href="https://doi.org/10.12688/f1000research.11198.1" target=_blank>https://doi.org/10.12688/f1000research.11198.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11198 id=mobile-track-article-signin-11198 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11198?target=/articles/6-1014"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12082 /> <input name=articleId type=hidden value=11198 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Yeonseok Chung</strong>, Laboratory of Immune Regulation, Research Institute for Pharmaceutical Sciences, College of Pharmacy, Seoul National University, South Korea </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Xiaoxia Li</strong>, Department of Immunology, Cleveland Clinic Lerner Research Institute, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1014&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1014&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23591-23856></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23592-23857></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1014/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>28 Jun 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Yeonseok Chung</strong>, Laboratory of Immune Regulation, Research Institute for Pharmaceutical Sciences, College of Pharmacy, Seoul National University, South Korea </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Xiaoxia Li</strong>, Department of Immunology, Cleveland Clinic Lerner Research Institute, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1014&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1014/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "New perspectives on the regulation of type...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1014/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1014/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1014/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Becerra-Díaz M et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1014/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1014",
            templates : {
                twitter : "New perspectives on the regulation of type II inflammation in.... Becerra-Díaz M et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1014/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: New perspectives on the regulation of type II inflammation in asthma", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: New perspectives on the regulation of type II inflammation in asthma", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11198/12082")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12082");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "23856": 0,
                           "23857": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "bdbd0930-8397-4737-be1d-e508fd78d1c1";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1014.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1014.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1014.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1014.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1014.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>